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Supplementary Material 1: Mean age of chronic patients in Denmark 
Table 1. Mean and std. dev. for men and women for each of the 199 conditions and chosen 
medicine. Data from Statistics Denmark 1st January 2013.  
Nr. Name of condition Mean age 
  Denmark Men Women 
  mean std. dev mean std. dev mean std. dev 
 
B –  Viral hepatitis and human immunodeficiency virus [HIV] 
disease 
46.9 12 48.3 11.9 44.3 11.9 
1 Chronic viral hepatitis  46 12.2 46.9 12 44.5 12.4 
2 Human immunodeficiency virus [HIV] disease 47.8 11.5 49.3 11.4 43.9 10.7 
 C – Malignant neoplasms 65.4 14.5 66.2 14.3 64.8 14.6 
3 Malignant neoplasms of other and unspecified localisations 62 14.9 62.8 14 60.9 15.7 
4 Malignant neoplasms of digestive organs 67.5 12.2 67.3 11.3 67.8 13.5 
5 Malignant neoplasm of colon 71.7 11.9 70.9 11.3 72.4 12.4 
6 
Malignant neoplasms of rectosigmoid junction, rectum, anus and 
anal canal 
70 11.2 70.1 10.6 70 12 
7 Malignant neoplasm of bronchus and lung 67.8 11.2 67.8 11.2 67.9 11.1 
8 Malignant melanoma of skin 59.4 16.5 61.8 15.5 57.6 16.9 
9 Other malignant neoplasms of skin 71.3 13.3 71.7 12.4 70.9 14.3 
10 Malignant neoplasm of breast 66 12 67.3 13.2 66 12 
11 Malignant neoplasms of female genital organs 63 14.1 - - 63 14.1 
12 
Malignant neoplasm of cervix uteri, corpus uteri and part 
unspecified 
63.8 14.8 0 0 63.8 14.8 
13 Malignant tumour of male genitalia 47.3 14.3 47.3 14.3 - - 
14 Malignant neoplasm of prostate 72.7 8.4 72.7 8.4 63.8 12.2 
15 Malignant neoplasms of urinary tract 70.2 11.8 70.3 11.4 70.1 12.8 
16 Brain cancer c   59.1 16 60 15.5 58.2 16.5 
17 
Malignant neoplasms of ill-defined, secondary and unspecified 
sites, and of independent (primary) multiple sites 
63.8 13.8 63.5 14 64 13.6 
18 
Malignant neoplasms, stated or presumed to be primary, of 
lymphoid, haematopoietic and related tissue 
62.6 17 61.8 16.7 63.6 17.3 
 
D – In situ and benign neoplasms, and  neoplasms of 
uncertain or unknown behaviour and diseases of the blood 
and blood-forming organs and certain disorders involving the 
immune mechanism 
60.6 19.2 63.5 17.4 59 19.9 
19 In situ neoplasms 57.6 16.5 67.3 14.4 55.2 16.1 
20 Haemolytic anaemias   50.9 19.9 53.9 19.9 49.4 19.7 
21 Aplastic and other anaemias   67.4 17.5 69.2 14.7 66.2 19.1 
22 Other anaemias   69.3 17.3 71.1 14.2 68.2 18.9 
23 Coagulation defects, purpura and other haemorrhagic conditions 50.3 18.2 54.8 17.4 47.6 18.1 
24 Other diseases of blood and blood-forming organs 57.8 16.6 57.6 16.2 57.9 16.9 
25 Certain disorders involving the immune mechanism 50.5 15.9 49.7 14.9 51.3 16.8 
 E – Endocrine, nutritional and metabolic diseases  63.7 14.5 63.8 13.2 63.7 15.5 
26 Diseases of the thyroid c 60.2 16.3 60.8 15.9 60.1 16.4 
27 Thyrotoxicosis c 61.5 17.4 63.1 15.4 61.1 17.8 
28 Diabetes type 1 c 47.5 17.2 47.2 16.7 47.9 17.9 
29 Diabetes type 2 c 65.5 13.1 65.3 11.7 65.7 14.5 
30 Diabetes others c 55.9 19.5 57.6 17 54.3 21.5 
31 Disorders of other endocrine glands 49 19.9 53.9 19.6 47.1 19.7 
32 Metabolic disorders 54 18.1 53.3 17.4 54.4 18.4 
33 Disturbances in lipoprotein circulation and other lipids c  66.5 11.7 65.3 11.6 67.9 11.7 
34 Cystic fibrosis c 40.4 16.5 40.3 16.5 40.5 16.4 
 G – Diseases of the nervous system 55.7 16.6 56.2 16.3 55.3 16.8 
35 Inflammatory diseases of the central nervous system 53 17.2 52.8 16.6 53.2 17.8 
36 Systemic atrophies primarily affecting the central nervous system 70.2 16.2 67.7 15.5 72.3 16.6 
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and other degenerative diseases  
37 Parkinson’s disease c 62.8 16 61.7 15.7 63.6 16.2 
38 Extrapyramidal and movement disorders 60.3 17.8 59.6 17.2 60.7 18.3 
39 Sclerosis  52.1 13.3 52.9 13.1 51.8 13.4 
40 Demyelinating diseases of the central nervous system  49 13.6 49.9 13.6 48.5 13.5 
41 Epilepsy c 53.3 18.2 52.7 17.7 53.8 18.7 
42 Migraine c 50.1 14.4 49.1 15 50.4 14.2 
43 Other headache syndromes 45.4 15.8 46.8 15.5 44.5 15.9 
44 
Transient cerebral ischaemic attacks and related syndromes and 
vascular syndromes of brain in cerebrovascular diseases 
68.4 13.5 67.5 12.6 69.5 14.5 
45 Sleep disorders 54.4 13.7 54.6 13.2 53.7 15 
46 Disorders of trigeminal nerve and facial nerve disorders  55.7 16.7 54.9 16.3 56.3 17 
47 
Disorders of other cranial nerves, cranial nerve disorders in 
diseases classified elsewhere, nerve root and plexus disorders and 
nerve root and plexus compressions in diseases classified 
elsewhere   
56.7 14.8 57.3 14.5 56.1 15 
48 Mononeuropathies of upper limb   56.8 14.8 56.4 14.4 57 15 
49 
Mononeuropathies of lower limb, other mononeuropathies and 
mononeuropathy in diseases classified elsewhere 
56.6 14.6 55.8 14.4 57.2 14.8 
50 
Polyneuropathies and other disorders of the peripheral nervous 
system 
63.3 15.1 63.2 14.2 63.3 16.2 
51 Diseases of myoneural junction and muscle 53 17.5 52.1 17.9 53.7 17.1 
52 Cerebral palsy and other paralytic syndromes 49.2 18.3 48.2 17.9 50.4 18.6 
53 Other disorders of the nervous system 55.9 17.7 56.9 17.1 55.1 18.2 
 
H – Diseases of the eye and adnexa and diseases of the ear and 
mastoid process 
66.4 16.8 65.3 16 67.5 17.3 
54 Disorders of eyelid, lacrimal system and orbit 62 15.9 63.7 15.7 60.9 15.9 
55 Corneal scars and opacities 59.5 18.4 57.9 17.8 61.7 18.9 
56 Other disorders of cornea 62.6 18.9 57.9 19 66.2 18 
57 Diseases of the eye lens (cataracts)  73.5 10.7 72.5 11.1 74.2 10.5 
58 Disorders of the choroid and retina 59.6 18.6 57.9 18 61.3 19 
59 Retinal vascular occlusions 71.5 13.1 70.1 12.4 72.9 13.6 
60 Other retinal disorders 73.7 14.5 70.6 15 75.8 13.7 
61 Retinal disorders in diseases classified elsewhere 59.3 15.4 59 14.5 59.6 16.5 
62 Glaucoma c 71.9 13.3 70.2 13.1 73.2 13.3 
63 Disorders of the vitreous body and globe  60 15.9 60.2 16.1 59.8 15.7 
64 Disorders of optic nerve and visual pathways 50.4 16.8 52.1 17 49.3 16.6 
65 
Disorders of ocular muscles, binocular movement, 
accommodation and refraction 
46.2 16.5 46.2 16.4 46.2 16.6 
66 Visual disturbances   58.2 18.1 57.2 17.7 59 18.5 
67 Blindness and partial sight  63.4 20.2 60.6 19 65.6 20.8 
68 
Nystagmus and other irregular eye movements and other disorders 
of eye and adnexa 
54.2 18.1 53.3 17.8 54.8 18.3 
69 Otosclerosis  61.4 15.8 61.4 15 61.4 16.3 
70 Ménière’s disease c 65.8 14.4 66.2 13.6 65.6 15 
71 Other diseases of the inner ear  68.6 12.1 69.2 11.5 62 15.8 
72 Conductive and sensorineural hearing loss 62.3 18.4 62 17.6 62.6 19.1 
73 
Other hearing loss and other disorders of ear not classified 
elsewhereclassified elsewhere  
61.7 17.5 62 16.6 61.3 18.5 
74 Presbycusis (age-related hearing loss)  79.7 10.3 77.9 9.7 81.3 10.6 
75 Hearing loss, unspecified  67.9 14.7 67.6 13.6 68.4 16 
76 Tinnitus 61.5 14.2 61.2 13.5 61.8 15.2 
77 Other specified disorders of ear 66.9 14.5 67.1 13.7 66.7 15.2 
 I – Diseases of the circulatory system 63.3 15.3 63.3 14 63.4 16.3 
78 Aortic and mitral valve disease c 72.4 14 70.7 13.2 74.2 14.5 
79 Hypertensive diseases c 65.2 14.1 65 12.7 65.3 15.2 
80 Heart failure c 71 13.2 69.3 12.5 74 13.8 
80A Ischaemic heart diseases 68.3 12.8 67.1 12.2 70.1 13.4 




      Acute myocardial infarction and  
      subsequent myocardial infarction 
68 13.1 66.2 12.4 71.5 13.6 
83       AMI complex/other  66.3 14.2 65.2 13.6 68 15 
84       Chronic ischaemic heart disease 70.4 11.9 68.9 11.4 73 12.5 
85 Pulmonary heart disease and diseases of pulmonary circulation 65.5 17.1 65.7 14.6 65.4 18.9 
86 Acute pericarditis  51.4 17.3 49.4 16.7 56.8 17.6 
87 Other forms of heart disease 61.8 18 60.4 17.7 64 18.1 
88 Atrioventricular and left bundle branch block 73.6 15 73 13.9 74.4 16.4 
89 Other conduction disorders 63.6 18.7 63 17.6 64.5 20 
90 Paroxysmal tachycardia 61.7 17.2 62.5 15.9 61 18.4 
91 Atrial fibrillation and flutter 72.6 12.7 70.1 12.4 75.8 12.4 
92 Other cardiac arrhythmias 65.5 16.9 66 15.5 65.1 18.1 
93 
Complications and ill-defined descriptions of heart disease and 
other heart disorders in diseases classified elsewhere 
64.1 17.5 64.5 16 63.8 18.9 
94 Stroke 69.4 13.6 68.3 12.6 70.7 14.6 
95 Cerebrovascular diseases 65.9 15 66.7 13.9 65 16 
96 Sequelae of cerebrovascular disease 71.4 13.2 70 12.3 72.9 14.1 
97 Atherosclerosis  71.6 12 70.3 11.2 73 12.6 
98 Aortic aneurysm and aortic dissection  71.7 11 71.6 10.4 72 12.5 
99 Diseases of arteries, arterioles and capillaries 60.5 16.5 62.9 15.3 58.4 17.1 
100 Other peripheral vascular diseases 68.6 12.9 68.3 11.5 68.9 14.4 
101 Phlebitis, thrombosis of the portal vein and others   60.9 17.3 61.3 15.2 60.6 19 
102 Varicose veins of lower extremities 55.2 15.5 57 15 54.4 15.7 
103 Haemorrhoids c 50.7 17.3 51.6 16.2 50.2 17.9 
104 
Oesophageal varices (chronic), varicose veins of other sites, other 
disorders of veins, non-specific lymphadenitis, other non-infective 
disorders of lymphatic vessels and lymph nodes and other and 
unspecified disorders of the circulatory system 
55.3 18.8 53 18.4 57.8 19 
 J – Diseases of the respiratory system 52.4 18.4 51.5 18.3 53 18.4 
105 Respiratory allergy c 51.5 18.2 50.3 18 52.4 18.3 
105A Chronic lower respiratory diseases c 55.4 17.1 54.9 17.4 55.7 17 
106 
  Bronchitis, not specified as acute 
   or chronic, simple and  
  mucopurulent chronic bronchitis  
  and unspecified chronic bronchitis 
68 14 67.9 13.6 68.1 14.3 
107    Emphysema 65.4 13.8 64.7 14 66.2 13.5 
108 Chronic obstructive lung disease (COPD) c 61.6 17.3 61.5 16.9 61.6 17.5 
109 Asthma, status asthmaticus c 52 19 50.8 19 52.8 18.9 
110    Bronchiectasis 62.6 14.7 60.8 15.1 63.6 14.4 
111 Other diseases of the respiratory system 63.3 16.5 62.5 16 64.2 16.9 
 K –  Diseases of the digestive system 57.4 18.4 57.5 17.3 57.3 19.3 
112 Ulcers c 60.3 18 59.6 16.9 60.8 18.7 
113 Inguinal hernia  60.1 16 60.2 15.6 58.9 18.6 
114 Ventral hernia 59.2 15.3 60.7 14.6 58 15.7 
115 Crohn’s diease  47.2 17.1 47 16.7 47.4 17.3 
116 Ulcerative colitis  51.3 17.5 51 17.1 51.6 17.9 
117 Other non-infective gastroenteritis and colitis 59 19.8 56.9 19.2 60.1 20 
118 Irritable bowel syndrome (IBS)  49.7 17.7 51 16.4 49.2 18.2 
119 Other functional intestinal disorders 59.2 20.3 60.4 19 58.5 21 
120 Diseases of liver, biliary tract and pancreas  57.9 15.1 56.9 14.4 58.8 15.7 
 L – Diseases of the skin and subcutaneous tissue 56.2 16.5 55.6 15.8 56.8 17.1 
121 Psoriasis c 56.2 16.5 55.6 15.8 56.8 17.1 
 
M – Diseases of the musculoskeletal system and connective 
tissue 
58.1 17.7 56.6 17 59.2 18.1 
122 Infectious arthropathies 50.4 16.7 50.6 16.4 50.3 17.1 
122A Inflammatory polyarthropathies and ankylosing spondylitis c 61.2 15.8 61.5 14.6 60.8 17 
123       Rheumatoid arthritis c 58 16.2 57.4 15.6 58.4 16.4 
124 
      Inflammatory polyarthropathies 
       – except rheumatoid arthritis c 
62.1 15.5 62.3 14.3 61.8 17.1 
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125 Polyarthrosis [arthrosis] 68.5 11.8 67 12.2 68.9 11.7 
126 Coxarthrosis [arthrosis of hip] 70.7 13 68.6 12.8 72.3 12.9 
127 Gonarthrosis [arthrosis of knee] 65.6 13.1 63.5 12.6 67.3 13.2 
128 Arthrosis of first carpometacarpal joint and other arthrosis 62.9 13.7 60.3 13.7 64.7 13.3 
129 Acquired deformities of fingers and toes  57.6 15.8 55.8 15.8 58 15.8 
130 Other acquired deformities of limbs  55 17.9 51.9 18.2 56.7 17.5 
131 Disorders of patella (knee cap) 36.4 13.4 37.7 13 35.5 13.6 
132 Internal derangement of knee  39.4 15.1 38.8 14.4 40.2 16 
133 Derangement of meniscus due to old tear or injury 47.7 15.1 46.5 14.4 49.1 15.8 
134 Internal derangement of knee, unspecified 43.9 16.4 43.7 15.4 44.2 17.3 
135 Other specific joint derangements 38.9 16.9 36.9 15.4 41.6 18.4 
136 Other joint disorders not classified elsewhere 48.4 16.7 48.4 17 48.3 16.5 
137 Systemic connective tissue disorders 62.2 18.6 65.6 17.2 61.1 18.9 
138 Systemic lupus erythematosus 53.1 15.5 55.3 16.3 52.8 15.3 
139 Dermatopolymyositis 58.4 15.6 57.1 14.4 59.2 16.4 
140 Systemic sclerosis 59.1 14.6 56.8 15.2 59.8 14.4 
141 Kyphosis, lordosis  50.6 16 48.2 16 52.8 15.6 
142 Scoliosis  43.2 20.7 40.8 19.8 44.3 21.1 
143 Spinal osteochondrosis  50 15.2 48.7 14.7 52.1 15.7 
144 Other deforming dorsopathies 58.8 15.6 56.1 15 60.9 15.7 
145 Other inflammatory spondylopathies 53.4 16.4 54.4 16.4 52.5 16.3 
146 Spondylosis 63.1 13.3 61.8 12.6 64.3 13.9 
147 
Other spondylopathies and spondylopathies in diseases classified 
elsewhere 
68.4 12.9 66.6 12.6 69.9 12.9 
148 Cervical disc disorders 51.7 11.7 52.3 11.5 51.3 11.8 
149 Other intervertebral disc disorders  52 14.7 51 14.1 52.9 15.3 
150 Other dorsopathies not classified elsewhere 49.6 15.7 50.1 15 49.2 16.1 
151 Dorsalgia 51.4 17.5 50.5 16.1 52.2 18.4 
152 Soft tissue disorders 46 17.5 49.6 17.9 44.6 17.2 
153 Synovitis and tenosynovitis  51.2 17.1 49.9 17 51.9 17.1 
154 Disorders of synovium and tendon 44.7 17.1 44.5 16.2 44.9 17.7 
155 Soft tissue disorders related to use, overuse and pressure 53.4 17.7 52.7 17.3 53.9 18.1 
156 Fibroblastic disorders 63 14.1 64.2 13.4 60.9 15 
157 Shoulder lesions  52.9 14.2 52.8 14.5 53 13.9 
158 Enthesopathies of lower limb, excluding foot 44.6 16.1 42.9 15.2 46.2 16.8 
159 Other enthesopathies 48.4 13.9 47 13.7 49.4 14 
160 Rheumatism, unspecified 54.7 13.3 53.8 15.5 54.8 12.9 
161 Myalgia  54.3 16 53.6 15.5 54.7 16.2 
162 Other soft tissue disorders, not classified elsewhere 50.8 16.5 51.6 16.1 50.3 16.7 
163 Other soft tissue disorders not classified elsewhere: pain in limb 51.3 18.7 50.4 17.8 52 19.2 
164 Fibromyalgia 50 12.5 51.1 12.9 49.9 12.5 
165 Osteoporosis c 72.1 11 70.4 11.8 72.4 10.9 
166 Osteoporosis in diseases classified elsewhere  63.9 15.8 60.9 16.5 65.6 15.2 
167 
Adult osteomalacia and other disorders of bone density and 
structure 
63.6 13.8 60.6 16.1 64.3 13 
168 Disorders of continuity of bone 50 19.6 45.1 18.6 55.2 19.3 
169 Other osteopathies 60.3 16.7 57.3 16.9 62.1 16.4 
170 
Other disorders of the musculoskeletal system and connective 
tissue 
51.5 17.7 49.2 16.8 54.1 18.2 
 N – Diseases of the genitourinary system 67.7 16.4 67.6 15.8 68 17.2 
171 Chronic renal failure (CRF) c 67.7 16.4 67.6 15.8 68 17.2 
 
Q – Congenital malformations, deformations and 
chromosomal abnormalities 
44.1 16.9 44.5 17.4 43.8 16.5 
172 
Congenital malformations: of the nervous, circulatory and 
respiratory systems, cleft palate and cleft lip, urinary tract, bones 
and muscles, other and chromosomal abnormalities not classified 
elsewhere 
43.4 16.7 43.4 17.5 43.5 16.2 
173 Congenital malformations of eye, ear, face and neck 41.2 16.1 42.1 16.7 40.6 15.8 
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c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Conditions marked ‘A’ overlap with other conditions 
and are thus not counted twice [1]. 
 
174 Other congenital malformations of the digestive system 55.9 18.8 54.6 18.4 56.8 19.1 
175 Congenital malformations of the sexual organs  45.7 15.5 46.9 16 43.6 14.2 
 F – Mental and behavioural disorders 50.5 19.3 49.2 18.5 51.4 19.9 
176 Dementia c 81.2 8.7 78.7 8.8 82.6 8.3 
177 Organic, including symptomatic, mental disorders 63.5 19.4 59.8 18.2 67 19.8 
178 Mental and behavioural disorders due to use of alcohol 50.3 16.3 50.2 15.8 50.7 17.1 
179 
Mental and behavioural disorders due to use of psychoactive 
substances  
44.8 17.3 44 16.8 45.9 17.8 
180 Schizophrenia c 44.9 15.1 43.7 13.8 46.7 16.6 
181 Schizotypal and delusional disorders 46.7 16.7 43.8 14.8 49.6 18 
182 Bipolar affective disorder c 52.7 16.8 51.6 15.8 53.4 17.4 
183 Depression c 52.8 18.7 52.3 17.5 53 19.3 
184 Mood (affective) disorders  50.4 17.5 49.8 16 50.7 18.3 
185 Phobic anxiety disorders 37.9 12.8 38.1 13 37.8 12.7 
186 Other anxiety disorders 44.5 16.6 44 15.3 44.8 17.1 
187 Obsessive compulsive disorder (OCD) c 35.1 14.3 35.5 14.4 34.9 14.3 
188 Post-traumatic stress disorder 44.4 12.1 45 11.5 43.9 12.5 
189 Reactions to severe stress and adjustment disorders 40.3 15.8 40.9 15.2 39.8 16.1 
190 
Dissociative (conversion) disorders, somatoform disorders and 
other neurotic disorders 
47.9 15.7 47.6 14.6 48.1 16.2 
191 Eating disorders 28.5 10.3 30.2 14.9 28.4 10 
192 
Behavioural syndromes associated with physiological 
disturbances and physical factors 
41.1 14.1 43 14.2 39.5 13.9 
193 Emotionally unstable personality disorder 37.5 12.2 40.6 11.4 36.7 12.2 
194 Specific personality disorders 42.5 14.1 42.6 13 42.5 14.9 
195 Disorders of adult personality and behaviour 42.2 13.6 43.4 12.8 41.4 14.2 
196 Mental retardation 42 16.9 41.1 16.5 43 17.2 
197 Disorders of psychological development 30 13.9 29.5 13.1 31 15.1 
198 Hyperkinetic disorders (ADHD) c 31.9 13.7 30.3 12.8 34.5 14.6 
199 
Behavioural and emotional disorders with onset usually occurring 
in childhood and adolescence 
40.9 16.8 39.8 15.9 41.9 17.6 
        
 Having one or more chronic conditions  53.2 18.3 52.9 17.8 53.4 18.7 
        
 Depression medicine c    ** 53.3 18.8 52.5 17.8 53.8 19.3 
 Antipsychotic medicine c    ** 51.1 19.1 48 18.1 53.7 19.6 
 Indication prescribed anxiety medicine c    ** 50.7 18.3 49 17.4 51.5 18.8 
 Heart failure medication c    ** 70 13.1 68.5 12.5 72.6 13.8 
 Ischaemic heart medication c    ** 72.3 12.5 70.2 11.8 74.6 12.9 
 All of the five types of medicine above 55.9 19.3 55.4 18.4 56.2 19.8 
        
 Others: arthrosis combined (M15-M19)  65.7 13.6 63.7 13.4 67.3 13.6 
 Others: overweight (E86) 46.9 15.6 54.8 14.8 45 15.1 
        




Supplementary Material 2: Age distribution of chronic patients in 
Denmark. 
 
Table 2. Age distribution in 7 categories of the 199 conditions and chosen medicine. Data 
from Statistics Denmark 1st January 2013. 
Nr. Name of condition N and prevalence 















  N 




B –  Viral hepatitis and human immunodeficiency 
virus [HIV] disease 
8,813 1.9 (2.0) 
0.4 1.7 3.2 3.4 2.4 0.9 0.3 
1 Chronic viral hepatitis  4,584 1.0 (1.0) 0.2 1.1 1.6 1.6 1.3 0.4 0.1 
2 Human immunodeficiency virus [HIV] disease 4,229 0.9 (0.9) 0.1 0.7 1.5 1.8 1.0 0.5 0.1 
 C – Malignant neoplasms 229,331 50.3 (50.4) 3.2 8.7 17.3 33.2 67.8 120.2 155.8 
3 
Malignant neoplasms of other and unspecified 
localisations 
20,557 4.5 (4.6) 
0.5 1.1 2.1 3.9 7.2 9.5 10.1 
4 Malignant neoplasms of digestive organs 4,839 1.1 (1.1) 0.0 0.1 0.2 0.5 1.6 2.9 3.4 
5 Malignant neoplasm of colon 18,826 4.1 (4.1) 0.1 0.1 0.4 1.4 4.3 10.2 20.3 
6 
Malignant neoplasms of rectosigmoid junction, 
rectum, anus and anal canal 
10,680 2.3 (2.3) 
0.0 0.1 0.2 1.0 3.0 6.4 9.5 
7 Malignant neoplasm of bronchus and lung 14,762 3.2 (3.3) 0.0 0.1 0.4 1.7 4.8 9.1 10.6 
8 Malignant melanoma of skin 19,636 4.3 (4.3) 0.5 1.9 3.4 4.1 5.4 8.1 9.0 
9 Other malignant neoplasms of skin 15,597 3.4 (3.4) 0.0 0.2 0.6 1.5 3.4 7.9 16.7 
10 Malignant neoplasm of breast 50,687 11.1 (11.1) 0.0 0.4 2.2 8.4 19.0 28.4 29.5 
11 Malignant neoplasms of female genital organs 7,245 1.6 (1.6) 0.1 0.2 0.7 1.6 2.5 3.2 3.9 
12 
Malignant neoplasm of cervix uteri, corpus uteri and 
part unspecified 
11,608 2.5 (2.5) 
0.0 0.5 1.4 2.0 3.6 5.4 7.1 
13 Malignant tumour of male genitalia 5,194 1.1 (1.1) 0.2 1.1 2.1 1.7 0.9 0.8 0.7 
14 Malignant neoplasm of prostate 26,697 5.9 (5.9) 0.0 0.0 0.0 0.5 5.2 19.7 27.0 
15 Malignant neoplasms of urinary tract 10,319 2.3 (2.3) 0.1 0.1 0.3 0.8 2.6 6.0 9.9 
16 Brain cancer c   15,310 3.4 (3.4) 0.7 1.4 2.0 3.1 4.9 6.8 6.2 
17 
Malignant neoplasms of ill-defined, secondary and 
unspecified sites, and of independent (primary) 
multiple sites 
25,619 5.6 (5.6) 
0.3 1.0 2.0 4.2 8.9 13.5 14.0 
18 
Malignant neoplasms, stated or presumed to be 
primary, of lymphoid, haematopoietic and related 
tissue 
19,712 4.3 (4.3) 
1.0 1.6 1.8 2.8 5.3 9.6 12.4 
 
D – In situ and benign neoplasms, and  neoplasms 
of uncertain or unknown behaviour and diseases 
of the blood and blood-forming organs and 
certain disorders involving the immune 
mechanism 
116,560 25.6 (25.7) 
5.5 13.7 19.2 21.5 25.6 36.9 80.1 
19 In situ neoplasms 19,810 4.3 (4.4) 0.2 2.6 4.3 4.1 5.5 7.3 7.9 
20 Haemolytic anaemias   3,055 0.7 (0.7) 0.4 0.8 0.8 0.6 0.5 0.7 1.2 
21 Aplastic and other anaemias   14,918 3.3 (3.3) 0.3 0.9 1.4 2.1 2.9 5.5 15.0 
22 Other anaemias   46,613 10.2 (10.3) 1.0 2.1 3.5 6.3 8.3 16.1 53.1 
23 
Coagulation defects, purpura and other haemorrhagic 
conditions 
25,376 5.6 (5.6) 
2.9 5.7 6.5 5.8 5.7 5.7 7.1 
24 Other diseases of blood and blood-forming organs 8,896 2.0 (2.0) 0.4 0.9 1.5 2.0 2.6 3.4 3.6 
25 Certain disorders involving the immune mechanism 7,660 1.7 (1.7) 0.5 1.4 2.2 2.1 2.1 1.9 1.3 
 E – Endocrine, nutritional and metabolic diseases  877,433 192.6 (192.7) 16.6 37.8 71.2 147.0 294.0 441.6 501.4 
26 Diseases of the thyroid c 131,908 29.0 (29.0) 3.7 10.0 18.9 29.4 41.7 49.1 66.2 
27 Thyrotoxicosis c 41,374 9.1 (9.0) 1.0 3.9 6.2 7.8 11.1 14.6 26.7 
28 Diabetes type 1 c 23,062 5.1 (5.1) 4.2 4.6 5.7 6.1 5.7 4.6 3.5 
29 Diabetes type 2 c 242,177 53.2 (53.3) 0.5 5.4 18.0 37.8 80.3 129.4 152.1 
30 Diabetes others c 1,117 0.2 (0.2) 0.1 0.2 0.2 0.2 0.3 0.4 0.5 
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31 Disorders of other endocrine glands 28,650 6.3 (6.4) 5.0 8.3 6.1 4.6 5.6 7.0 8.9 
32 Metabolic disorders 23,690 5.2 (5.2) 2.0 4.0 5.0 5.2 6.1 7.2 8.2 
33 
Disturbances in lipoprotein circulation and other 
lipids c  
652,242 143.2 (143.1) 
1.1 5.9 25.9 94.3 233.4 378.1 408.1 
34 Cystic fibrosis c 947 0.2 (0.2) 0.2 0.3 0.3 0.1 0.1 0.1 0.1 
 G – Diseases of the nervous system 561,054 123.2 (123.5) 29.6 67.1 108.6 146.5 173.0 170.8 188.6 
35 Inflammatory diseases of the central nervous system 7,642 1.7 (1.7) 0.5 1.3 1.8 1.9 1.9 2.3 2.2 
36 
Systemic atrophies primarily affecting the central 
nervous system and other degenerative diseases  
10,401 2.3 (2.3) 
0.2 0.5 0.6 1.0 2.0 4.0 12.1 
37 Parkinson’s disease c 57,583 12.6 (12.6) 0.9 3.7 7.2 11.3 16.1 23.2 37.3 
38 Extrapyramidal and movement disorders 10,837 2.4 (2.4) 0.6 1.1 1.5 2.0 2.9 4.1 6.4 
39 Sclerosis  13,284 2.9 (2.9) 0.3 1.7 3.5 4.5 4.6 3.3 1.5 
40 Demyelinating diseases of the central nervous system  4,571 1.0 (1.0) 0.2 0.9 1.4 1.5 1.3 0.8 0.4 
41 Epilepsy c 61,695 13.5 (13.6) 6.9 9.9 12.0 14.6 16.3 17.5 20.3 
42 Migraine c 149,866 32.9 (33.0) 10.5 23.9 38.2 49.4 49.3 30.9 15.6 
43 Other headache syndromes 16,469 3.6 (3.6) 2.6 4.0 5.1 4.8 3.4 2.3 1.8 
44 
Transient cerebral ischaemic attacks and related 
syndromes and vascular syndromes of brain in 
cerebrovascular diseases 
43,977 9.7 (9.7) 
0.2 0.7 2.3 5.6 12.4 22.5 37.6 
45 Sleep disorders 36,806 8.1 (8.1) 1.4 3.6 6.8 11.3 14.3 12.3 5.0 
46 
Disorders of trigeminal nerve and facial nerve 
disorders  
21,488 4.7 (4.7) 
1.0 2.8 4.5 5.4 6.1 6.8 7.4 
47 
Disorders of other cranial nerves, cranial nerve 
disorders in diseases classified elsewhere, nerve root 
and plexus disorders and nerve root and plexus 
compressions in diseases classified elsewhere   
12,429 2.7 (2.7) 
0.3 1.0 2.4 3.6 4.3 4.2 3.6 
48 Mononeuropathies of upper limb   122,395 26.9 (26.9) 1.7 10.6 23.6 35.4 44.4 37.7 36.5 
49 
Mononeuropathies of lower limb, other 
mononeuropathies and mononeuropathy in diseases 
classified elsewhere 
18,627 4.1 (4.1) 
0.4 1.6 3.4 5.3 6.5 6.6 5.0 
50 
Polyneuropathies and other disorders of the 
peripheral nervous system 
30,289 6.6 (6.7) 
0.5 1.4 3.0 5.5 9.9 13.5 18.2 
51 Diseases of myoneural junction and muscle 5,758 1.3 (1.3) 0.6 0.9 1.2 1.4 1.6 1.7 1.6 
52 Cerebral palsy and other paralytic syndromes 14,410 3.2 (3.2) 2.4 3.1 3.0 3.5 3.5 3.4 3.2 
53 Other disorders of the nervous system 44,394 9.7 (9.8) 3.4 5.9 8.2 9.9 12.0 15.1 17.0 
 
H – Diseases of the eye and adnexa and diseases of 
the ear and mastoid process 
448,176 98.4 (98.6) 
13.1 24.0 37.6 58.1 104.6 195.6 394.4 
54 Disorders of eyelid, lacrimal system and orbit 13,191 2.9 (2.9) 0.4 0.6 1.6 3.0 3.8 5.4 7.5 
55 Corneal scars and opacities 2,173 0.5 (0.5) 0.1 0.3 0.3 0.4 0.5 0.7 1.3 
56 Other disorders of cornea 9,473 2.1 (2.1) 0.4 1.0 1.5 1.5 2.0 3.3 7.4 
57 Diseases of the eye lens (cataracts)  68,009 14.9 (15.1) 0.2 0.4 0.8 3.1 11.1 37.6 84.8 
58 Disorders of the choroid and retina 1,900 0.4 (0.4) 0.1 0.2 0.3 0.4 0.5 0.6 1.1 
59 Retinal vascular occlusions 10,358 2.3 (2.3) 0.0 0.1 0.3 0.9 2.3 5.1 11.4 
60 Other retinal disorders 68,485 15.0 (15.1) 0.4 1.2 3.0 5.3 10.5 26.2 93.7 
61 Retinal disorders in diseases classified elsewhere 19,279 4.2 (4.3) 0.6 1.7 2.7 3.9 6.5 8.6 7.4 
62 Glaucoma c 67,310 14.8 (14.9) 0.5 0.9 2.1 5.3 14.2 33.1 76.4 
63 Disorders of the vitreous body and globe  7,572 1.7 (1.7) 0.3 0.7 0.9 1.2 2.7 3.5 3.1 
64 Disorders of optic nerve and visual pathways 6,184 1.4 (1.4) 0.6 1.2 1.6 1.7 1.6 1.4 1.4 
65 
Disorders of ocular muscles, binocular movement, 
accommodation and refraction 
18,247 4.0 (4.0) 
2.6 4.8 5.5 5.1 3.4 2.9 2.8 
66 Visual disturbances   22,232 4.9 (4.9) 1.2 3.0 3.5 4.4 6.1 7.7 11.1 
67 Blindness and partial sight  6,614 1.5 (1.5) 0.4 0.6 0.8 1.1 1.5 1.9 5.6 
68 
Nystagmus and other irregular eye movements and 
other disorders of eye and adnexa 
11,133 2.4 (2.5) 
1.1 1.7 2.1 2.6 2.9 3.5 3.7 
69 Otosclerosis  10,360 2.3 (2.3) 0.3 0.5 1.4 2.2 3.2 4.4 5.4 
70 Ménière’s disease c 10,003 2.2 (2.2) 0.1 0.2 0.8 1.7 3.1 4.5 7.3 
71 Other diseases of the inner ear  29,865 6.6 (6.3) 0.1 0.4 1.1 3.0 8.5 17.6 24.5 
72 Conductive and sensorineural hearing loss 43,238 9.5 (9.6) 3.2 3.5 4.4 6.2 11.0 18.4 29.5 
73 
Other hearing loss and other disorders of ear, not 
classified elsewhere  
8,306 1.8 (1.8) 
0.4 0.6 1.0 1.5 2.3 3.2 5.2 
74 Presbycusis (age-related hearing loss)  80,659 17.7 (17.6) 0.2 0.3 0.6 1.4 4.9 26.2 147.4 
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75 Hearing loss, unspecified  87,806 19.3 (19.3) 1.9 2.5 4.5 9.6 23.2 46.3 74.5 
76 Tinnitus 40,124 8.8 (8.7) 0.5 1.9 4.7 8.5 14.7 18.3 17.5 
77 Other specified disorders of ear 20,537 4.5 (4.4) 0.5 0.6 1.2 2.4 5.7 11.0 16.1 
 I – Diseases of the circulatory system 1,254,427 275.4 (275.5) 20.6 66.3 124.2 231.6 398.8 563.6 753.9 
78 Aortic and mitral valve disease c 30,123 6.6 (6.6) 0.4 0.6 1.0 2.2 5.4 13.3 37.7 
79 Hypertensive diseases c 1,060,046 232.7 (232.7) 6.5 33.0 79.5 183.3 348.3 509.5 695.8 
80 Heart failure c 37,540 8.2 (8.3) 0.2 0.5 1.3 3.4 9.1 18.1 40.3 
80A Ischaemic heart diseases 139,173 30.6 (30.7) 0.3 1.1 5.7 19.3 42.5 71.4 114.5 
81       Angina pectoris 78,476 17.2 (17.3) 0.2 0.7 3.7 12.6 26.8 41.9 53.0 
82 
      Acute myocardial infarction and  
      subsequent myocardial infarction 
36,654 8.0 (8.1) 
0.1 0.3 1.6 5.8 11.5 17.7 29.8 
83       AMI complex/other  2,969 0.7 (0.7) 0.0 0.1 0.2 0.5 0.9 1.3 2.3 
84       Chronic ischaemic heart disease 84,592 18.6 (18.6) 0.1 0.3 2.0 8.8 23.2 44.8 81.4 
85 
Pulmonary heart disease and diseases of pulmonary 
circulation 
15,352 3.4 (3.4) 
0.5 1.0 1.4 2.0 3.5 6.6 13.0 
86 Acute pericarditis  5,563 1.2 (1.2) 0.5 1.1 1.3 1.3 1.5 1.5 1.3 
87 Other forms of heart disease 8,119 1.8 (1.8) 0.4 0.8 1.0 1.3 2.0 3.3 5.4 
88 Atrioventricular and left bundle branch block 14,604 3.2 (3.2) 0.2 0.4 0.6 0.9 2.1 5.8 20.0 
89 Other conduction disorders 11,823 2.6 (2.6) 0.6 1.1 1.2 1.8 2.7 4.4 9.5 
90 Paroxysmal tachycardia 39,510 8.7 (8.7) 1.9 3.4 4.5 6.4 11.0 17.0 23.9 
91 Atrial fibrillation and flutter 112,342 24.7 (24.7) 0.4 1.3 3.1 7.7 22.9 55.9 132.0 
92 Other cardiac arrhythmias 34,418 7.6 (7.6) 0.8 2.0 3.5 5.1 8.4 14.0 28.8 
93 
Complications and ill-defined descriptions of heart 
disease and other heart disorders in diseases 
classified elsewhere 
7,337 1.6 (1.6) 
0.3 0.6 0.7 1.0 1.8 3.0 5.7 
94 Stroke 72,606 15.9 (16.0) 0.3 1.1 3.1 8.8 19.3 35.3 68.7 
95 Cerebrovascular diseases 17,308 3.8 (3.8) 0.3 0.7 1.3 2.4 4.9 8.3 13.3 
96 Sequelae of cerebrovascular disease 50,952 11.2 (11.2) 0.2 0.6 1.6 5.0 11.9 24.2 55.9 
97 Atherosclerosis  32,064 7.0 (7.0) 0.1 0.2 0.7 2.4 7.5 17.3 34.2 
98 Aortic aneurysm and aortic dissection  10,296 2.3 (2.3) 0.0 0.1 0.2 0.6 1.9 6.3 11.2 
99 Diseases of arteries, arterioles and capillaries 11,830 2.6 (2.6) 0.4 0.9 1.7 2.5 3.4 4.7 6.2 
100 Other peripheral vascular diseases 28,508 6.3 (6.3) 0.3 0.5 1.1 2.9 7.6 16.3 24.4 
101 Phlebitis, thrombosis of the portal vein and others   37,388 8.2 (8.3) 1.3 3.2 5.5 7.5 9.8 14.1 22.2 
102 Varicose veins of lower extremities 23,530 5.2 (5.2) 0.5 2.6 6.0 6.4 6.7 7.6 6.6 
103 Haemorrhoids c 74,285 16.3 (16.3) 5.1 17.4 20.1 18.6 16.8 16.9 19.0 
104 
Oesophageal varices (chronic), varicose veins of 
other sites, other disorders of veins, non-specific 
lymphadenitis, other non-infective disorders of 
lymphatic vessels and lymph nodes and other and 
unspecified disorders of the circulatory system 
15,194 3.3 (3.3) 
1.7 2.2 2.6 3.1 4.1 4.9 6.1 
 J – Diseases of the respiratory system 1,210,598 265.7 (266.3) 139.1 218.4 261.3 279.4 296.4 327.8 381.9 
105 Respiratory allergy c 841,685 184.8 (185.2) 96.2 162.8 195.7 196.6 202.7 216.7 240.3 
105
A 
Chronic lower respiratory diseases c 418,120 91.8 (92.0) 
17.3 66.5 84.8 104.5 111.0 125.9 156.3 
106 
  Bronchitis, not specified as acute 
   or chronic, simple and  
  mucopurulent chronic bronchitis  
  and unspecified chronic bronchitis 
12,790 2.8 (2.8) 
0.1 0.3 0.7 1.6 3.5 6.2 11.3 
107    Emphysema 5,557 1.2 (1.2) 0.0 0.2 0.4 0.9 1.8 2.8 3.7 
108 Chronic obstructive lung disease (COPD) c 216,184 47.5 (47.6) 14.5 15.8 21.8 35.6 61.5 93.3 131.4 
109 Asthma, status asthmaticus c 361,129 79.3 (79.4) 54.3 62.7 73.8 77.6 86.4 98.9 118.4 
110    Bronchiectasis 4,362 1.0 (1.0) 0.1 0.2 0.5 0.7 1.5 2.2 2.2 
111 Other diseases of the respiratory system 21,993 4.8 (4.9) 0.7 1.5 2.2 3.5 6.0 10.0 14.6 
 K –  Diseases of the digestive system 329,337 72.3 (72.6) 23.7 44.1 53.8 68.0 87.5 109.7 157.4 
112 Ulcers c 157,379 34.5 (34.8) 8.7 14.9 21.4 30.8 42.8 57.4 91.9 
113 Inguinal hernia  25,032 5.5 (5.5) 1.0 1.9 3.3 5.2 7.7 11.0 11.5 
114 Ventral hernia 7,941 1.7 (1.7) 0.2 0.6 1.3 1.9 2.4 3.3 3.3 
115 Crohn’s diease  18,913 4.2 (4.2) 2.5 5.0 5.5 4.6 4.0 3.5 3.4 
116 Ulcerative colitis  29,538 6.5 (6.5) 2.5 6.3 7.2 7.3 7.2 7.0 8.2 
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117 Other non-infective gastroenteritis and colitis 20,844 4.6 (4.6) 1.9 2.9 2.7 3.3 4.9 7.3 12.8 
118 Irritable bowel syndrome (IBS)  37,593 8.3 (8.3) 4.1 9.8 8.5 8.8 9.0 9.2 8.4 
119 Other functional intestinal disorders 51,933 11.4 (11.5) 5.0 7.0 7.4 8.7 11.6 16.3 34.1 
120 Diseases of liver, biliary tract and pancreas  26,956 5.9 (6.0) 0.9 2.3 3.8 6.7 10.0 10.4 8.5 
 L – Diseases of the skin and subcutaneous tissue 65,469 14.4 (14.5) 3.4 7.8 12.0 15.5 20.4 23.0 21.7 
121 Psoriasis c 65,469 14.4 (14.5) 3.4 7.8 12.0 15.5 20.4 23.0 21.7 
 
M – Diseases of the musculoskeletal system and 
connective tissue 
1,032,808 226.7 (227.1) 
73.2 107.4 152.2 217.7 303.2 376.4 470.5 
122 Infectious arthropathies 9,402 2.1 (2.1) 0.7 2.0 2.6 2.5 2.2 2.2 2.1 
122
A 
Inflammatory polyarthropathies and ankylosing 
spondylitis c 
165,944 36.4 (36.5) 
4.2 11.0 21.5 33.8 52.5 70.2 84.9 
123       Rheumatoid arthritis c 77,345 17.0 (17.0) 2.9 7.0 13.4 17.8 24.3 29.0 30.5 
124 
      Inflammatory polyarthropathies 
       – except rheumatoid arthritis c 
115,945 25.5 (25.5) 
2.2 7.4 13.2 22.8 37.0 50.6 63.3 
125 Polyarthrosis [arthrosis] 16,935 3.7 (3.7) 0.0 0.1 0.5 1.7 6.2 9.6 12.6 
126 Coxarthrosis [arthrosis of hip] 104,115 22.9 (22.7) 0.5 1.6 3.7 9.2 23.8 54.3 108.1 
127 Gonarthrosis [arthrosis of knee] 178,811 39.3 (39.4) 0.5 2.7 10.8 32.2 62.3 89.8 113.5 
128 
Arthrosis of first carpometacarpal joint and other 
arthrosis 
91,101 20.0 (20.1) 
0.7 3.0 8.1 18.3 35.1 43.4 43.4 
129 Acquired deformities of fingers and toes  55,730 12.2 (12.3) 3.0 5.3 7.8 12.4 19.7 23.3 17.1 
130 Other acquired deformities of limbs  20,584 4.5 (4.5) 2.3 2.7 3.2 4.6 6.3 6.9 6.9 
131 Disorders of patella (knee cap) 38,999 8.6 (8.6) 13.9 16.1 11.6 8.3 4.1 1.7 0.6 
132 Internal derangement of knee  9,192 2.0 (2.0) 2.9 3.0 2.6 2.3 1.3 0.8 0.4 
133 Derangement of meniscus due to old tear or injury 36,374 8.0 (8.0) 5.4 6.0 8.8 12.1 10.9 6.8 2.5 
134 Internal derangement of knee, unspecified 28,206 6.2 (6.2) 6.9 6.4 7.2 8.0 6.2 4.0 2.3 
135 Other specific joint derangements 5,923 1.3 (1.3) 2.2 2.1 1.4 1.1 0.8 0.6 0.5 
136 Other joint disorders not classified elsewhere 12,043 2.6 (2.7) 1.8 2.2 2.9 3.6 3.2 2.2 1.9 
137 Systemic connective tissue disorders 42,631 9.4 (9.4) 1.8 4.4 6.2 7.2 8.9 15.0 32.3 
138 Systemic lupus erythematosus 3,376 0.7 (0.7) 0.2 0.5 0.8 0.9 1.1 1.0 0.7 
139 Dermatopolymyositis 1,137 0.2 (0.2) 0.0 0.1 0.2 0.2 0.4 0.5 0.4 
140 Systemic sclerosis 1,675 0.4 (0.4) 0.0 0.1 0.2 0.4 0.6 0.8 0.5 
141 Kyphosis, lordosis  4,160 0.9 (0.9) 0.4 0.6 1.1 1.2 1.2 1.0 0.7 
142 Scoliosis  17,686 3.9 (3.9) 6.7 5.3 3.2 2.5 2.7 3.0 4.3 
143 Spinal osteochondrosis  8,034 1.8 (1.8) 0.6 1.4 2.1 2.5 2.4 1.7 1.0 
144 Other deforming dorsopathies 23,756 5.2 (5.3) 0.7 1.8 3.8 5.9 7.6 8.9 9.9 
145 Other inflammatory spondylopathies 7,086 1.6 (1.6) 0.3 1.1 1.8 2.0 1.9 1.9 2.0 
146 Spondylosis 61,999 13.6 (13.6) 0.2 1.2 5.4 14.4 24.0 27.0 31.4 
147 
Other spondylopathies and spondylopathies in 
diseases classified elsewhere 
50,805 11.2 (11.2) 
0.1 0.7 2.4 6.2 14.9 26.0 43.7 
148 Cervical disc disorders 11,476 2.5 (2.5) 0.1 0.9 3.2 5.1 3.9 1.9 1.2 
149 Other intervertebral disc disorders  40,161 8.8 (8.9) 1.4 5.8 11.3 12.8 11.4 9.6 7.6 
150 Other dorsopathies not classified elsewhere 7,246 1.6 (1.6) 0.6 1.3 2.1 2.2 1.9 1.4 1.2 
151 Dorsalgia 40,780 9.0 (9.0) 3.5 7.2 10.7 11.6 9.6 8.3 11.9 
152 Soft tissue disorders 13,422 2.9 (3.0) 2.5 3.5 3.6 3.4 2.5 2.2 2.4 
153 Synovitis and tenosynovitis  19,104 4.2 (4.2) 2.6 3.1 3.6 4.8 6.4 4.9 3.8 
154 Disorders of synovium and tendon 19,669 4.3 (4.3) 4.7 4.5 4.9 5.1 4.3 3.3 2.1 
155 
Soft tissue disorders related to use, overuse and 
pressure 
11,090 2.4 (2.4) 
1.3 1.5 2.1 2.8 3.0 3.4 3.4 
156 Fibroblastic disorders 43,600 9.6 (9.6) 0.5 1.5 4.5 8.7 14.1 21.8 22.6 
157 Shoulder lesions  58,112 12.8 (12.7) 3.3 6.0 11.6 20.5 20.7 15.0 8.6 
158 Enthesopathies of lower limb, excluding foot 11,223 2.5 (2.5) 2.4 2.5 3.0 3.3 2.5 1.6 0.9 
159 Other enthesopathies 10,500 2.3 (2.3) 0.9 1.6 3.1 4.1 2.8 1.6 1.0 
160 Rheumatism, unspecified 6,852 1.5 (1.5) 0.1 0.5 1.4 2.4 2.7 1.8 1.2 
161 Myalgia  10,168 2.2 (2.2) 0.4 1.3 2.3 3.1 3.1 2.5 3.0 
162 Other soft tissue disorders not classified elsewhere 7,939 1.7 (1.7) 0.6 1.7 2.0 2.1 2.2 1.9 1.7 
163 
Other soft tissue disorders not classified elsewhere: 
pain in limb 
22,201 4.9 (4.9) 
3.4 3.5 4.7 5.7 5.4 5.2 6.7 
164 Fibromyalgia 3,399 0.7 (0.7) 0.1 0.5 1.0 1.4 1.1 0.5 0.3 
 
11 
165 Osteoporosis c 158,813 34.9 (34.8) 0.1 0.4 1.3 8.4 45.0 89.2 163.6 
166 Osteoporosis in diseases classified elsewhere  1,007 0.2 (0.2) 0.0 0.1 0.1 0.2 0.3 0.5 0.7 
167 
Adult osteomalacia and other disorders of bone 
density and structure 
43,271 9.5 (9.5) 
0.7 1.8 3.0 6.9 16.7 21.9 22.7 
168 Disorders of continuity of bone 1,865 0.4 (0.4) 0.4 0.3 0.3 0.4 0.5 0.5 0.5 
169 Other osteopathies 24,251 5.3 (5.3) 1.0 2.1 3.2 4.7 7.2 9.9 12.4 
170 
Other disorders of the musculoskeletal system and 
connective tissue 
30,038 6.6 (6.6) 
2.8 6.0 7.1 7.5 7.4 7.4 8.2 
 N – Diseases of the genitourinary system 20,162 4.4 (4.5) 0.5 0.9 1.5 2.5 4.3 8.3 20.0 
171 Chronic renal failure (CRF) c 20,162 4.4 (4.5) 0.5 0.9 1.5 2.5 4.3 8.3 20.0 
 
Q – Congenital malformations, deformations and 
chromosomal abnormalities 
124,898 27.4 (27.5) 
24.2 38.9 38.0 27.1 21.6 19.6 16.2 
172 
Congenital malformations: of the nervous, 
circulatory and respiratory systems, cleft palate and 
cleft lip, urinary tract, bones and muscles, other and 
chromosomal abnormalities not classified elsewhere 
85,534 18.8 (18.9) 
18.1 26.9 25.8 18.6 14.7 12.7 9.8 
173 Congenital malformations of eye, ear, face and neck 19,689 4.3 (4.3) 4.5 7.7 6.3 3.7 2.9 2.3 1.8 
174 
Other congenital malformations of the digestive 
system 
6,481 1.4 (1.4) 
0.6 1.0 1.2 1.2 1.6 2.1 2.9 
175 Congenital malformations of the sexual organs  16,192 3.6 (3.6) 1.7 4.5 5.9 4.1 2.8 2.8 1.9 
 F – Mental and behavioural disorders 683,194 150.0 (150.7) 104.9 145.7 152.1 155.7 154.3 138.1 223.7 
176 Dementia c 36,803 8.1 (8.1) 0.0 0.0 0.0 0.3 1.6 10.6 71.7 
177 Organic, including symptomatic, mental disorders 26,430 5.8 (5.9) 1.0 2.7 3.6 4.5 5.8 7.6 22.6 
178 
Mental and behavioural disorders due to use of 
alcohol 
59,143 13.0 (13.2) 
8.8 8.7 10.4 17.6 19.5 15.1 7.9 
179 
Mental and behavioural disorders due to use of 
psychoactive substances  
53,669 11.8 (11.9) 
11.9 15.5 12.6 12.8 11.2 9.0 7.2 
180 Schizophrenia c 29,422 6.5 (6.5) 4.1 8.6 8.5 8.4 6.8 3.9 2.2 
181 Schizotypal and delusional disorders 39,694 8.7 (8.8) 5.4 10.8 11.1 10.5 8.8 6.2 6.2 
182 Bipolar affective disorder c 22,669 5.0 (5.0) 1.7 4.0 5.0 5.7 6.7 6.1 5.7 
183 Depression c 454,933 99.9 (100.2) 45.4 87.2 101.0 107.1 111.6 103.1 165.8 
184 Mood (affective) disorders  6,887 1.5 (1.5) 0.6 1.6 1.7 1.7 1.7 1.4 1.7 
185 Phobic anxiety disorders 14,324 3.1 (3.2) 3.3 6.6 5.0 3.0 1.7 0.6 0.3 
186 Other anxiety disorders 38,079 8.4 (8.4) 6.0 12.7 11.2 9.3 7.1 4.8 5.3 
187 Obsessive compulsive disorder (OCD) c 10,062 2.2 (2.2) 4.0 4.9 2.7 1.4 0.8 0.5 0.5 
188 Post-traumatic stress disorder 16,055 3.5 (3.6) 1.3 3.9 6.0 6.1 3.4 1.0 0.4 
189 Reactions to severe stress and adjustment disorders 61,701 13.5 (13.7) 18.8 19.9 17.2 14.9 9.9 4.8 4.4 
190 
Dissociative (conversion) disorders, somatoform 
disorders and other neurotic disorders 
21,420 4.7 (4.7) 
2.0 4.9 6.5 6.4 5.0 3.6 3.1 
191 Eating disorders 7,751 1.7 (1.7) 5.2 4.2 1.4 0.5 0.2 0.1 0.1 
192 
Behavioural syndromes associated with 
physiological disturbances and physical factors 
6,163 1.4 (1.3) 
0.9 2.6 2.1 1.4 1.0 0.5 0.3 
193 Emotionally unstable personality disorder 21,848 4.8 (4.9) 5.0 10.2 7.9 4.7 2.3 0.8 0.2 
194 Specific personality disorders 50,415 11.1 (11.2) 6.8 18.5 17.3 13.3 8.9 4.9 2.7 
195 Disorders of adult personality and behaviour 17,533 3.8 (3.9) 2.3 6.4 6.2 4.9 3.0 1.5 0.7 
196 Mental retardation 13,822 3.0 (3.1) 4.3 4.0 3.2 3.2 2.7 1.8 1.2 
197 Disorders of psychological development 9,911 2.2 (2.2) 7.4 3.8 1.5 0.9 0.6 0.4 0.3 
198 Hyperkinetic disorders (ADHD) c 42,908 9.4 (9.5) 26.3 15.9 10.2 5.8 2.7 1.4 1.0 
199 
Behavioural and emotional disorders with onset 
usually occurring in childhood and adolescence 
39,602 8.7 (8.8) 
11.9 13.8 10.0 8.4 6.3 4.5 3.7 
            
 Having one or more chronic conditions  2,989,441 656.2 (657.2) 338.1 493.3 591.0 678.9 788.1 877.2 953.9 















 Depression medicine c    ** 529,918 116.3 (116.7) 54.5 93.4 113.8 124.3 130.1 126.8 201.9 
 Antipsychotic medicine c    ** 138,625 30.4 (30.6) 20.2 27.1 30.3 32.9 32.2 30.2 44.8 
 Indication prescribed anxiety medicine c    ** 102,568 22.5 (22.6) 12.4 21.6 24.7 24.9 24.2 21.4 30.1 
 Heart failure medication c    ** 7,468 1.6 (1.7) 0.0 0.1 0.2 0.8 1.9 3.6 7.5 
 Ischaemic heart medication c    ** 129,484 28.4 (28.5) 0.2 0.7 2.9 10.9 29.8 63.1 147.3 
 All of the five types of medicine above 688,006 151.0 (151.6) 64.8 104.5 126.8 145.5 167.6 192.2 331.1 
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c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Conditions marked ‘A’ overlap with other conditions 
and are thus not counted twice [1]. Standardised estimates in brackets.  
 Others: arthrosis combined (M15-M19)  338,166 74.2 (74.3) 1.7 7.3 22.1 57.3 113.2 166.7 226.3 





Supplementary Material 3: Comments on selected national conditions, 
overview means and prevalences of number of conditions (comorbidity)  
In the following, some selected conditions are commented upon. The selection is not complete 
with regard to all interesting findings, as this is not possible. The selected conditions are 
choosen as they are common, have some disparities,  and are included in the national health 
profiles so that they can be compared to self-reported estaimtes [2].  
 
Register-based arthrosis has a lower register-based prevalence than the self-reported estimate 
of 19.7% [2], including when register diagnoses M15–M19 are summarised (N = 338,166 or 
7.4% of the population). A recent European study confirmed both varying and higher 
prevalence rates than those of the current study [3]. Since arthrosis affects most people around 
the age of 60–80 [3], but does not necessarily cause limitations, the condition is not expected 
to be reported by hospitals or GPs for all patients. Therefore, it is not necessarily ‘chronic’ by 
the definition of the current study if there is no functional or medical need. Nevertheless, no 
there is no reported disease-specific medicine used exclusively for osteoarthritis that can be 
used here, and the validity of using medication indication codes seems poor, with only a few 
uses, making it difficult to use registers to include the condition fully.  
 
Although migraine is defined along with the unclear term ‘frequent headaches’ in the self-
reported survey (14.5%) [2], the register-based estimates of ‘migraine’ and ‘headache 
unspecified’ of 4.9% and 0.4%, respectively, are also lower than in a Norwegian study 
measuring the prevalence of migraine (12.0%) and headache (37.7%), respectively [4]. 
Comparisons are, however, difficult, since the referenced study measured 1-year prevalence, 
which is  not comparable with the definition in the current study. In addition, the Danish self-
reported migraine and ‘frequent headaches’ [2] is a case example of a less severe condition 
with overlapping, ill-defined aetiology and high variability that for many cases may not be 
chronic by the definition of this study, thereby illustrating again the scope of challenges in 
providing reliable estimates. However, the prevalence estimates in the current study are 
probably still too low.  
 
With regard to tinnitus, there are differences ranging between 0.9% for the current study and 
the self-reported estimate of 12.1% [2]; other studies show higher prevalences ranging from 
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4.4 to 15.1% [5]. Also, other studies show that only 1% have severely reduced quality of life 
due to tinnitus [6], suggesting a high variability in the severity of tinnitus and thereby also 
meeting the definition of ‘chronic’. However, many may still be treated by private specialists 
without reporting the condition, which may be the most prevalent reason for possible register 
under-reporting. Thus, further validation might consider including economic settlement 
information for hearing aids if possible, while at the same time observing changes in the 
register-based prevalence. 
 
As regards cataracts, which have a self-reported prevalence of 4.1% [2], a recent literature 
review identified a much higher prevalence of cataracts, indicating the register estimates in 
the current study to be too low [7].  Furthermore, as with ear conditions, eye conditions are 
often treated by private specialists who do not yet report to the NPR. Thus, further validation 
and development of the register-based definition of cataracts might be considered for future 





Table 3. Overview: N, prevalence rate per thousand, age and gender (per cent within gender) 
of disease groups of conditions and chosen medicines for Denmark at 1 January 2013. 
Standardised rates or mean std. dev. in brackets. See table with 10-year age intervals in 
Supplementary Material 2. 
 
c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Conditions marked ‘A’ overlap with other conditions 
and are thus not counted twice [1]. 
Name of condition ICD-10 code /  definition N and prevalence 








  N 





B –  Viral hepatitis and human immunodeficiency 
virus [HIV] disease 
B18, B20–B24 8,813 1.9 (2.0) 65.3 1.8 2.4 0.3 
C – Malignant neoplasms 
C00–C99; D32–D33; D35.2–
D35.4; D42–D44  
229,331 50.3 (50.4) 43.3 10.2 69.4 155.8 
D – In situ and benign neoplasms, and  neoplasms 
of uncertain or unknown behaviour and diseases of 
the blood and blood-forming organs and certain 
disorders involving the immune mechanism 
D00–D09; D55–D59; D60–D67; 
D80–D89 
116,560 25.6 (25.7) 36.3 13.2 27.3 80.1 
E – Endocrine, nutritional and metabolic diseases  
E00–E14; E20–E29; E31–35; 
E70–E78; E84–E85; E88–E89 
877,433 192.6 (192.7) 45.6 43.5 279.6 501.4 
G – Diseases of the nervous system 
G00–G14; G20–G32; G35–G37; 
G40–47; G50–64; G70–73; 
G80–G83; G90–G99 
561,054 123.2 (123.5) 40.1 70.6 162.2 188.6 
H – Diseases of the eye and adnexa and diseases of 
the ear and mastoid process 
H02–H06; H17–H18; H25–H28; 
H31–H32; H34–H36; H40–55; 
H57; H80,H810; H93, H90–H93 
448,176 98.4 (98.6) 47.5 25.6 112.6 394.4 
I – Diseases of the circulatory system 
I05–I06; I10–28; I30–33;I36–
141; I44–I52; I60–I88; I90–I94; 
I96–I99 
1,254,427 275.4 (275.5) 45.3 73.3 381.5 753.9 
J – Diseases of the respiratory system 
J30.1; J40–J47; J60–J84; J95, 
J97–J99 
1,210,598 265.7 (266.3) 42.1 209.3 298.8 381.9 
K –  Diseases of the digestive system 
K25–K27; K40, K43, K50–52; 
K58–K59;  K71–K77; K86–K87  
329,337 72.3 (72.6) 44.7 41.3 86.3 157.4 
L – Diseases of the skin and subcutaneous tissue L40 65,469 14.4 (14.5) 47.8 7.9 19.3 21.7 




1,032,808 226.7 (227.1) 42.2 113.2 291.2 470.5 
N – Diseases of the genitourinary system N18 20,162 4.4 (4.5) 59.4 1.0 4.8 20.0 
Q – Congenital malformations, deformations and 
chromosomal abnormalities 
Q00–Q56; Q60–Q99 124,898 27.4 (27.5) 41.7 33.9 23.2 16.2 
F – Mental and behavioural disorders F00–99 683,194 150.0 (150.7) 41.0 135.2 150.2 223.7 
Having one or more chronic conditions   2,989,441 656.2 (657.2) 45.5 480.5 771.5 953.9 









         
Depression medicine c    ** ATC: N06A. 529,918 116.3 (116.7) 36.3 88.7 126.9 201.9 
Antipsychotic medicine c    ** ATC: N05A. 138,625 30.4 (30.6) 45.7 26.1 31.9 44.8 
Indication prescribed anxiety medicine c    ** 
All prescriptions with either 
indication codes 163 (for 
anxiety) or 371 (for anxiety, 
addictive) 
102,568 22.5 (22.6) 34.5 19.9 23.7 30.1 
Heart failure medication c    ** 
ATC: C01AA05, C03, C07 or 
C09A with indication code 430 
(for heart failure) 
7,468 1.6 (1.7) 64.6 0.1 2.0 7.5 
Ischaemic heart medication c    ** 
ATC: C01A, C01B, C01D, 
C01E. 
129,484 28.4 (28.5) 51.8 1.4 32.0 147.3 
All of the five types of medicine above  688,006 151.0 (151.6) 40.4 100.2 166.1 331.1 
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The maximum number of chronic conditions, one person have, is 36. In the tables below, 
prevelences of number of conditions are presented by gender and age. 
 
Table 4. Number of conditions by age in per cent and means (comorbidity) 

















0 condition 66.2 50.7 40.9 32.1 21.2 12.3 4.6 1,565,998 34.4 
1 condition 19.5 23.6 24.9 23.2 19.2 14.5 7.8 906,365 19.9 
2 conditions 7.6 11.6 14.1 15.5 16.3 15.0 10.6 601,767 13.2 
3 conditions 3.5 6.5 8.5 10.6 12.9 14.0 12.3 435,614 9.6 
4 conditions 1.6 3.4 4.8 6.8 9.4 11.6 12.1 306,882 6.7 
5 conditions 0.8 1.8 2.8 4.3 6.7 9.1 11.3 218,183 4.8 
6 conditions 0.4 1.0 1.6 2.7 4.7 6.8 9.7 155,685 3.4 
7 conditions 0.2 0.6 0.9 1.7 3.2 5.0 7.9 109,688 2.4 
8 conditions 0.1 0.3 0.6 1.1 2.1 3.6 6.3 77,563 1.7 
9 conditions 0.1 0.2 0.4 0.7 1.4 2.5 4.8 54,429 1.2 
10 or more conditions 0.1 0.3 0.6 1.3 2.9 5.7 12.7 123,265 2.7 
Total % 100 100 100 100 100 100 100 4,555,439 100 
N 648,269 650,285 760,514 801,708 694,862 594,029 405,772 - - 
Mean nmb. 
conditions (std. dev.) 0.6 (1.2) 1.1 (1.6) 1.4 (1.9) 1.9 (2.3) 2.8 (2.8) 3.8 (3.2) 5.3 (3.6) 2.2 (2,8) - 
 
Table 5. Number of conditions by gender and age in per cent and means (comorbidity) 
















Men          
0 condition 69.3 56.9 47.4 37.3 24.7 13.8 5.3 881,465 39.3 
1 condition 18.8 22.4 24.0 23.1 19.5 14.7 8.3 444,066 19.8 
2 conditions 6.8 9.9 12.4 14.3 15.8 14.7 10.7 274,281 12.2 
3 conditions 2.9 5.3 7.2 9.6 12.2 13.7 12.1 194,328 8.7 
4 conditions 1.2 2.6 3.8 5.9 8.9 11.4 11.8 133,575 6.0 
5 or more conditions 
1.1 2.9 5.1 9.9 19.0 31.8 51.8 314,707 14.0 
Total % 
100.1 100 99.9 100.1 100.1 100.1 100 - 100 
N 331,170 327,436 381,978 404,507 345,379 288,496 163,456 2,242,422 - 
Mean number of 
conditions (std. dev.) 
0.5 (1.0) 0.9 (1.4) 1.2 (1.7) 1.7 (2.2) 2.6 (2.7) 3.7 (3.2) 5.3 (5.7) 2.0 (2.6) - 




















0 condition 63.0 44.4 34.3 26.9 17.8 10.9 4.1 684,533 29.6 
1 condition 20.3 24.7 25.8 23.3 19.0 14.2 7.5 462,299 20.0 
2 conditions 8.5 13.2 15.8 16.7 16.9 15.4 10.5 327,486 14.2 
3 conditions 4.1 7.7 9.8 11.6 13.5 14.2 12.4 241,286 10.4 
4 conditions 2.0 4.4 5.8 7.7 10.0 11.8 12.3 173,307 7.5 
5 or more conditions 
2.2 5.7 8.6 13.8 22.9 33.5 53.3 424,106 18.3 
Total % 100.1 100.1 100.1 100 100.1 100 100.1 - 100 
N 317,099 322,849 378,536 397,201 349,483 305,533 242,316 2,313,017 - 
Mean number of 
conditions (std. dev.) 
0.7 (1.3) 1.3 (1.8) 1.7 (2.0) 2.2 (2.4) 3.0 82.8) 3.8 (3.2) 5.4 (3.6) 2.4 (2.9) - 
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Supplementary Material 4: Regional differences standardised - for all 199 conditions 
Table 6. N and prevalence of conditions and medicine for Denmark and the five regions – standardised by age, gender and 
education at 1 January 2013  
Nr Condition Denmark 





























B –  Viral hepatitis and human 
immunodeficiency virus [HIV] disease 
8,940 2.0 4,167 2.9 1,896 1.8 481 1.0 1,451 1.5 944 1.4 
1 Chronic viral hepatitis  4,654 1.0 1,700 1.2 1,288 1.3 281 0.6 934 1.0 450 0.7 
2 Human immunodeficiency virus [HIV] disease 4,286 0.9 2,467 1.7 609 0.6 200 0.4 517 0.5 493 0.7 
 C – Malignant neoplasms 229,685 50.4 74,242 52.5 51,797 50.5 21,623 45.5 47,436 48.6 34,587 52.0 
3 
Malignant neoplasms of other and unspecified 
localisations 
20,810 4.6 8,281 5.9 4,208 4.1 2,047 4.3 3,170 3.2 3,104 4.7 
4 Malignant neoplasms of digestive organs 4,879 1.1 1,774 1.3 998 1.0 440 0.9 921 0.9 746 1.1 
5 Malignant neoplasm of colon 18,898 4.1 6,600 4.7 3,765 3.7 1,808 3.8 3,669 3.8 3,056 4.6 
6 
Malignant neoplasms of rectosigmoid junction, 
rectum, anus and anal canal 
10,681 2.3 3,365 2.4 2,269 2.2 1,167 2.5 2,220 2.3 1,660 2.5 
7 Malignant neoplasm of bronchus and lung 14,824 3.3 3,331 2.4 5,582 5.4 1,063 2.2 3,041 3.1 1,807 2.7 
8 Malignant melanoma of skin 19,639 4.3 7,327 5.2 3,459 3.4 1,423 3.0 4,266 4.4 3,164 4.8 
9 Other malignant neoplasms of skin 15,679 3.4 5,137 3.6 3,443 3.4 933 2.0 4,013 4.1 2,153 3.2 
10 Malignant neoplasm of breast 50,777 11.1 16,446 11.6 11,379 11.1 4,791 10.1 11,309 11.6 6,852 10.3 
11 Malignant neoplasms of female genital organs 7,177 1.6 2,229 1.6 1,202 1.2 635 1.3 1,312 1.3 1,799 2.7 
12 
Malignant neoplasm of cervix uteri, corpus 
uteri and part unspecified 
11,537 2.5 3,430 2.4 2,240 2.2 1,205 2.5 2,294 2.4 2,368 3.6 
13 Malignant tumour of male genitalia 5,210 1.1 1,679 1.2 1,115 1.1 526 1.1 1,075 1.1 816 1.2 
14 Malignant neoplasm of prostate 26,701 5.9 8,435 6.0 5,791 5.6 3,224 6.8 5,300 5.4 3,952 5.9 
15 Malignant neoplasms of urinary tract 10,291 2.3 2,989 2.1 2,363 2.3 1,245 2.6 2,113 2.2 1,580 2.4 
16 Brain cancer c   15,364 3.4 5,284 3.7 3,155 3.1 1,546 3.3 2,719 2.8 2,660 4.0 
17 
Malignant neoplasms of ill-defined, secondary 
and unspecified sites, and of independent 
(primary) multiple sites 
25,708 5.6 6,162 4.4 9,278 9.0 2,498 5.3 4,832 5.0 2,939 4.4 
18 
Malignant neoplasms, stated or presumed to be 
primary, of lymphoid, haematopoietic and 
related tissue 
19,703 4.3 6,205 4.4 4,419 4.3 1,744 3.7 4,580 4.7 2,756 4.1 
 
D – In situ and benign neoplasms, and  
neoplasms of uncertain or unknown 
behaviour and diseases of the blood and 
blood-forming organs and certain disorders 
involving the immune mechanism 
117,140 25.7 35,823 25.4 29,089 28.3 10,527 22.1 24,421 25.0 17,281 26.0 
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19 In situ neoplasms 19,901 4.4 6,233 4.4 3,895 3.8 2,149 4.5 4,640 4.8 2,984 4.5 
20 Haemolytic anaemias   3,041 0.7 1,082 0.8 736 0.7 239 0.5 602 0.6 383 0.6 
21 Aplastic and other anaemias   15,108 3.3 5,627 4.0 2,976 2.9 1,449 3.0 2,570 2.6 2,486 3.7 
22 Other anaemias   46,815 10.3 14,234 10.1 10,811 10.5 4,184 8.8 10,404 10.7 7,182 10.8 
23 
Coagulation defects, purpura and other 
haemorrhagic conditions 
25,524 5.6 7,015 5.0 8,804 8.6 1,762 3.7 4,362 4.5 3,581 5.4 
24 
Other diseases of blood and blood-forming 
organs 
8,904 2.0 2,782 2.0 2,160 2.1 707 1.5 1,962 2.0 1,292 1.9 
25 
Certain disorders involving the immune 
mechanism 
7,648 1.7 2,056 1.5 1,850 1.8 895 1.9 1,749 1.8 1,099 1.7 
 
E – Endocrine, nutritional and metabolic 
diseases  
877,683 192.7 260,800 184.6 203,022 197.8 94,353 198.4 194,071 198.9 125,437 188.7 
26 Diseases of the thyroid c 131,909 29.0 41,838 29.6 28,311 27.6 11,427 24.0 29,059 29.8 21,274 32.0 
27 Thyrotoxicosis c 41,200 9.0 11,616 8.2 9,815 9.6 5,624 11.8 9,616 9.9 4,529 6.8 
28 Diabetes type 1 c 23,120 5.1 6,547 4.6 5,482 5.3 2,502 5.3 5,282 5.4 3,307 5.0 
29 Diabetes type 2 c 242,682 53.3 73,650 52.1 55,267 53.8 24,685 51.9 53,782 55.1 35,299 53.1 
30 Diabetes others c 1,127 0.2 348 0.2 226 0.2 86 0.2 314 0.3 153 0.2 
31 Disorders of other endocrine glands 28,944 6.4 8,283 5.9 7,932 7.7 2,086 4.4 7,072 7.2 3,571 5.4 
32 Metabolic disorders 23,723 5.2 7,038 5.0 6,076 5.9 1,887 4.0 5,486 5.6 3,238 4.9 
33 
Disturbances in lipoprotein circulation and 
other lipids c  
652,111 143.1 189,944 134.4 154,201 150.2 73,443 154.4 143,266 146.8 91,256 137.3 
34 Cystic fibrosis c 928 0.2 467 0.3 121 0.1 57 0.1 127 0.1 156 0.2 
 G – Diseases of the nervous system 562,699 123.5 160,082 113.3 133,562 130.1 55,326 116.3 128,695 131.9 85,035 128.0 
35 
Inflammatory diseases of the central nervous 
system 
7,669 1.7 2,479 1.8 1,748 1.7 660 1.4 1,661 1.7 1,121 1.7 
36 
Systemic atrophies primarily affecting the 
central nervous system and other degenerative 
diseases  
10,566 2.3 4,567 3.2 1,741 1.7 574 1.2 1,748 1.8 1,937 2.9 
37 Parkinson’s disease c 57,565 12.6 15,991 11.3 13,669 13.3 6,524 13.7 13,482 13.8 7,899 11.9 
38 Extrapyramidal and movement disorders 10,893 2.4 3,329 2.4 2,961 2.9 936 2.0 2,308 2.4 1,360 2.0 
39 Sclerosis  13,317 2.9 3,969 2.8 3,071 3.0 1,210 2.5 3,033 3.1 2,033 3.1 
40 
Demyelinating diseases of the central nervous 
system  
4,562 1.0 1,167 0.8 1,009 1.0 523 1.1 1,055 1.1 808 1.2 
41 Epilepsy c 61,993 13.6 16,933 12.0 15,888 15.5 6,260 13.2 13,761 14.1 9,152 13.8 
42 Migraine c 150,385 33.0 44,956 31.8 33,119 32.3 15,622 32.8 33,423 34.3 23,266 35.0 
43 Other headache syndromes 16,580 3.6 5,896 4.2 3,296 3.2 1,239 2.6 3,913 4.0 2,235 3.4 
44 
Transient cerebral ischaemic attacks and related 
syndromes and vascular syndromes of brain in 
cerebrovascular diseases 
44,079 9.7 13,052 9.2 10,491 10.2 4,941 10.4 9,415 9.6 6,180 9.3 
45 Sleep disorders 36,919 8.1 10,856 7.7 9,235 9.0 4,070 8.6 7,403 7.6 5,355 8.1 
46 
Disorders of trigeminal nerve and facial nerve 
disorders  
21,602 4.7 7,018 5.0 4,482 4.4 1,789 3.8 5,244 5.4 3,069 4.6 
47 
Disorders of other cranial nerves, cranial nerve 
disorders in diseases classified elsewhere, nerve 
12,512 2.7 3,913 2.8 2,635 2.6 917 1.9 3,546 3.6 1,502 2.3 
 
19 
root and plexus disorders and nerve root and 
plexus compressions in diseases classified 
elsewhere   
48 Mononeuropathies of upper limb   122,454 26.9 26,653 18.9 35,077 34.2 11,924 25.1 33,372 34.2 15,428 23.2 
49 
Mononeuropathies of lower limb, other 
mononeuropathies and mononeuropathy in 
diseases classified elsewhere 
18,671 4.1 4,627 3.3 5,132 5.0 1,570 3.3 5,096 5.2 2,247 3.4 
50 
Polyneuropathies and other disorders of the 
peripheral nervous system 
30,571 6.7 9,208 6.5 8,020 7.8 2,489 5.2 7,683 7.9 3,171 4.8 
51 Diseases of myoneural junction and muscle 5,763 1.3 1,857 1.3 1,314 1.3 545 1.1 1,173 1.2 873 1.3 
52 Cerebral palsy and other paralytic syndromes 14,481 3.2 4,021 2.8 3,514 3.4 1,371 2.9 3,154 3.2 2,421 3.6 
53 Other disorders of the nervous system 44,422 9.8 14,714 10.4 5,459 5.3 2,262 4.8 6,718 6.9 15,269 23.0 
 
H – Diseases of the eye and adnexa and 
diseases of the ear and mastoid process 
448,968 98.6 143,318 101.4 101,054 98.5 46,479 97.7 96,865 99.3 61,251 92.2 
54 Disorders of eyelid, lacrimal system and orbit 13,194 2.9 3,404 2.4 3,262 3.2 1,809 3.8 3,475 3.6 1,243 1.9 
55 Corneal scars and opacities 2,165 0.5 323 0.2 808 0.8 314 0.7 485 0.5 235 0.4 
56 Other disorders of cornea 9,546 2.1 2,243 1.6 3,371 3.3 1,127 2.4 1,793 1.8 1,013 1.5 
57 Diseases of the eye lens (cataracts)  68,649 15.1 23,971 17.0 16,442 16.0 5,716 12.0 13,989 14.3 8,532 12.8 
58 Disorders of the choroid and retina 1,901 0.4 538 0.4 343 0.3 263 0.6 464 0.5 294 0.4 
59 Retinal vascular occlusions 10,389 2.3 3,450 2.4 2,353 2.3 946 2.0 2,200 2.3 1,440 2.2 
60 Other retinal disorders 68,812 15.1 22,318 15.8 16,247 15.8 6,461 13.6 14,329 14.7 9,457 14.2 
61 
Retinal disorders in diseases classified 
elsewhere 
19,366 4.3 3,233 2.3 9,131 8.9 1,313 2.8 3,138 3.2 2,550 3.8 
62 Glaucoma c 67,747 14.9 21,365 15.1 17,976 17.5 6,712 14.1 13,265 13.6 8,430 12.7 
63 Disorders of the vitreous body and globe  7,631 1.7 2,212 1.6 2,148 2.1 1,139 2.4 1,400 1.4 733 1.1 
64 Disorders of optic nerve and visual pathways 6,221 1.4 2,012 1.4 1,227 1.2 789 1.7 1,318 1.4 875 1.3 
65 
Disorders of ocular muscles, binocular 
movement, accommodation and refraction 
18,251 4.0 6,125 4.3 3,702 3.6 2,321 4.9 3,495 3.6 2,609 3.9 
66 Visual disturbances   22,250 4.9 5,732 4.1 5,580 5.4 3,763 7.9 4,537 4.6 2,639 4.0 
67 Blindness and partial sight  6,778 1.5 2,818 2.0 1,194 1.2 650 1.4 1,226 1.3 891 1.3 
68 
Nystagmus and other irregular eye movements 
and other disorders of eye and adnexa 
11,296 2.5 6,300 4.5 1,817 1.8 878 1.8 1,291 1.3 1,010 1.5 
69 Otosclerosis  10,345 2.3 3,431 2.4 1,931 1.9 1,040 2.2 2,310 2.4 1,633 2.5 
70 Ménière’s disease c 9,957 2.2 2,946 2.1 1,911 1.9 877 1.8 2,576 2.6 1,646 2.5 
71 Other diseases of the inner ear  28,906 6.3 5,035 3.6 4,470 4.4 5,778 12.1 9,582 9.8 4,040 6.1 
72 Conductive and sensorineural hearing loss 43,621 9.6 16,235 11.5 9,435 9.2 4,372 9.2 7,911 8.1 5,668 8.5 
73 
Other hearing loss and other disorders of ear 
not classified elsewhere  
8,203 1.8 2,304 1.6 1,298 1.3 758 1.6 2,627 2.7 1,215 1.8 
74 Presbycusis (age-related hearing loss)  80,204 17.6 26,707 18.9 11,827 11.5 10,608 22.3 20,101 20.6 10,962 16.5 
75 Hearing loss, unspecified  87,991 19.3 30,062 21.3 17,632 17.2 7,536 15.8 18,987 19.5 13,774 20.7 
76 Tinnitus 39,683 8.7 12,548 8.9 5,570 5.4 6,057 12.7 9,898 10.1 5,611 8.4 
77 Other specified disorders of ear 19,907 4.4 3,159 2.2 2,455 2.4 2,023 4.3 6,968 7.1 5,302 8.0 
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 I – Diseases of the circulatory system 1,255,023 275.5 371,814 263.1 282,908 275.6 135,244 284.3 279,542 286.5 185,516 279.2 
78 Aortic and mitral valve disease c 29,962 6.6 7,073 5.0 8,402 8.2 2,868 6.0 7,501 7.7 4,119 6.2 
79 Hypertensive diseases c 1,059,864 232.7 314,316 222.4 237,405 231.3 116,916 245.8 235,211 241.0 156,016 234.8 
80 Heart failure c 38,025 8.3 14,808 10.5 7,413 7.2 2,593 5.5 7,224 7.4 5,989 9.0 
80A Ischaemic heart diseases 139,703 30.7 43,566 30.8 34,076 33.2 12,962 27.3 26,948 27.6 22,150 33.3 
81       Angina pectoris 78,972 17.3 23,590 16.7 22,676 22.1 7,849 16.5 14,303 14.7 10,553 15.9 
82 
      Acute myocardial infarction and  
      subsequent myocardial infarction 
36,762 8.1 11,662 8.3 8,094 7.9 3,252 6.8 7,605 7.8 6,150 9.3 
83       AMI complex/other  2,988 0.7 1,136 0.8 301 0.3 127 0.3 389 0.4 1,035 1.6 
84       Chronic ischaemic heart disease 84,808 18.6 26,962 19.1 18,589 18.1 7,524 15.8 16,812 17.2 14,921 22.5 
85 
Pulmonary heart disease and diseases of 
pulmonary circulation 
15,436 3.4 5,424 3.8 2,993 2.9 1,195 2.5 3,452 3.5 2,372 3.6 
86 Acute pericarditis  5,551 1.2 1,809 1.3 1,118 1.1 438 0.9 1,273 1.3 913 1.4 
87 Other forms of heart disease 8,147 1.8 2,729 1.9 1,647 1.6 686 1.4 1,820 1.9 1,264 1.9 
88 Atrioventricular and left bundle branch block 14,678 3.2 4,403 3.1 3,586 3.5 1,415 3.0 3,133 3.2 2,141 3.2 
89 Other conduction disorders 11,867 2.6 3,886 2.8 2,406 2.3 1,041 2.2 2,478 2.5 2,056 3.1 
90 Paroxysmal tachycardia 39,538 8.7 11,797 8.3 9,180 8.9 4,053 8.5 7,429 7.6 7,079 10.7 
91 Atrial fibrillation and flutter 112,555 24.7 35,826 25.4 25,564 24.9 11,295 23.7 23,498 24.1 16,373 24.6 
92 Other cardiac arrhythmias 34,563 7.6 10,084 7.1 8,585 8.4 2,947 6.2 7,758 8.0 5,190 7.8 
93 
Complications and ill-defined descriptions of 
heart disease and other heart disorders in 
diseases classified elsewhere 
7,476 1.6 3,042 2.2 2,135 2.1 315 0.7 1,289 1.3 695 1.0 
94 Stroke 72,852 16.0 23,619 16.7 16,560 16.1 5,969 12.5 15,247 15.6 11,457 17.2 
95 Cerebrovascular diseases 17,432 3.8 6,095 4.3 3,440 3.4 1,576 3.3 4,422 4.5 1,899 2.9 
96 Sequelae of cerebrovascular disease 50,969 11.2 15,868 11.2 10,020 9.8 4,568 9.6 12,509 12.8 8,004 12.0 
97 Atherosclerosis  31,893 7.0 9,023 6.4 6,217 6.1 2,666 5.6 8,119 8.3 5,868 8.8 
98 Aortic aneurysm and aortic dissection  10,349 2.3 3,244 2.3 2,542 2.5 836 1.8 2,282 2.3 1,444 2.2 
99 Diseases of arteries, arterioles and capillaries 11,932 2.6 4,288 3.0 2,747 2.7 867 1.8 2,540 2.6 1,490 2.2 
100 Other peripheral vascular diseases 28,582 6.3 8,375 5.9 6,680 6.5 2,784 5.9 7,332 7.5 3,413 5.1 
101 
Phlebitis, thrombosis of the portal vein and 
others   
37,596 8.3 13,128 9.3 6,361 6.2 3,871 8.1 7,843 8.0 6,393 9.6 
102 Varicose veins of lower extremities 23,783 5.2 5,180 3.7 7,327 7.1 3,107 6.5 7,095 7.3 1,074 1.6 
103 Haemorrhoids c 74,298 16.3 18,692 13.2 18,236 17.8 7,832 16.5 18,093 18.5 11,445 17.2 
104 
Oesophageal varices (chronic), varicose veins 
of other sites, other disorders of veins, non-
specific lymphadenitis, other non-infective 
disorders of lymphatic vessels and lymph nodes 
and other and unspecified disorders of the 
circulatory system 
15,140 3.3 4,254 3.0 2,928 2.9 1,199 2.5 3,067 3.1 3,693 5.6 
 J – Diseases of the respiratory system 1,213,221 266.3 386,289 273.4 268,734 261.8 123,547 259.8 259,163 265.6 175,489 264.1 
105 Respiratory allergy c 843,779 185.2 274,999 194.6 187,675 182.9 84,923 178.5 175,370 179.7 120,812 181.8 
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105A Chronic lower respiratory diseases c 419,143 92.0 134,854 95.4 88,387 86.1 41,732 87.7 93,289 95.6 60,880 91.6 
106 
  Bronchitis, not specified as acute 
   or chronic, simple and  
  mucopurulent chronic bronchitis  
  and unspecified chronic bronchitis 
12,837 2.8 3,950 2.8 2,642 2.6 1,216 2.6 3,532 3.6 1,497 2.3 
107    Emphysema 5,547 1.2 1,475 1.0 1,557 1.5 523 1.1 972 1.0 1,019 1.5 
108 Chronic obstructive lung disease (COPD) c 216,724 47.6 66,326 46.9 49,420 48.2 22,002 46.3 48,216 49.4 30,760 46.3 
109 Asthma, status asthmaticus c 361,502 79.4 110,250 78.0 81,603 79.5 38,571 81.1 78,429 80.4 52,649 79.2 
110    Bronchiectasis 4,402 1.0 1,128 0.8 1,628 1.6 499 1.0 504 0.5 643 1.0 
111 Other diseases of the respiratory system 22,104 4.9 7,004 5.0 4,834 4.7 1,647 3.5 5,499 5.6 3,120 4.7 
 K –  Diseases of the digestive system 330,894 72.6 100,693 71.3 72,578 70.7 33,677 70.8 73,000 74.8 50,946 76.7 
112 Ulcers c 158,342 34.8 53,838 38.1 31,932 31.1 15,402 32.4 30,945 31.7 26,226 39.5 
113 Inguinal hernia  25,014 5.5 7,049 5.0 5,699 5.6 2,942 6.2 5,682 5.8 3,641 5.5 
114 Ventral hernia 7,953 1.7 2,134 1.5 1,829 1.8 906 1.9 1,845 1.9 1,239 1.9 
115 Crohn’s diease  19,012 4.2 6,198 4.4 4,155 4.0 1,758 3.7 3,711 3.8 3,190 4.8 
116 Ulcerative colitis  29,552 6.5 8,201 5.8 7,134 7.0 2,812 5.9 6,788 7.0 4,616 6.9 
117 Other non-infective gastroenteritis and colitis 20,847 4.6 5,839 4.1 4,271 4.2 1,995 4.2 5,053 5.2 3,690 5.6 
118 Irritable bowel syndrome (IBS)  37,822 8.3 8,988 6.4 7,342 7.2 4,808 10.1 11,026 11.3 5,658 8.5 
119 Other functional intestinal disorders 52,273 11.5 13,687 9.7 15,532 15.1 4,796 10.1 12,321 12.6 5,938 8.9 
120 Diseases of liver, biliary tract and pancreas  27,133 6.0 9,397 6.7 5,390 5.3 2,294 4.8 5,686 5.8 4,367 6.6 
 
L – Diseases of the skin and subcutaneous 
tissue 
65,862 14.5 23,014 16.3 15,014 14.6 5,974 12.6 12,746 13.1 9,114 13.7 
121 Psoriasis c 65,862 14.5 23,014 16.3 15,014 14.6 5,974 12.6 12,746 13.1 9,114 13.7 
 
M – Diseases of the musculoskeletal system 
and connective tissue 
1,034,337 227.1 289,995 205.2 247,475 241.1 104,052 218.8 251,281 257.5 141,534 213.0 
122 Infectious arthropathies 9,418 2.1 3,132 2.2 2,034 2.0 917 1.9 1,994 2.0 1,340 2.0 
122A 
Inflammatory polyarthropathies and ankylosing 
spondylitis c 
166,122 36.5 53,788 38.1 34,621 33.7 15,712 33.0 35,938 36.8 26,064 39.2 
123       Rheumatoid arthritis c 77,262 17.0 25,157 17.8 16,602 16.2 7,191 15.1 15,900 16.3 12,412 18.7 
124 
      Inflammatory polyarthropathies 
       – except rheumatoid arthritis c 
116,094 25.5 37,000 26.2 23,674 23.1 11,154 23.5 26,175 26.8 18,092 27.2 
125 Polyarthrosis [arthrosis] 17,065 3.7 5,164 3.7 4,494 4.4 1,182 2.5 4,238 4.3 1,987 3.0 
126 Coxarthrosis [arthrosis of hip] 103,546 22.7 30,927 21.9 23,242 22.6 10,435 21.9 23,470 24.1 15,473 23.3 
127 Gonarthrosis [arthrosis of knee] 179,292 39.4 53,673 38.0 40,460 39.4 20,873 43.9 39,052 40.0 25,235 38.0 
128 
Arthrosis of first carpometacarpal joint and 
other arthrosis 
91,578 20.1 27,501 19.5 22,567 22.0 7,981 16.8 21,470 22.0 12,059 18.1 
129 Acquired deformities of fingers and toes  55,827 12.3 14,983 10.6 14,056 13.7 4,372 9.2 14,168 14.5 8,250 12.4 
130 Other acquired deformities of limbs  20,601 4.5 4,195 3.0 6,179 6.0 2,055 4.3 6,038 6.2 2,134 3.2 
131 Disorders of patella (knee cap) 39,332 8.6 9,172 6.5 12,009 11.7 5,218 11.0 8,321 8.5 4,612 6.9 
132 Internal derangement of knee  9,141 2.0 3,733 2.6 1,362 1.3 683 1.4 2,031 2.1 1,332 2.0 




134 Internal derangement of knee, unspecified 28,382 6.2 6,767 4.8 8,270 8.1 2,181 4.6 7,940 8.1 3,224 4.9 
135 Other specific joint derangements 5,932 1.3 2,333 1.7 1,171 1.1 437 0.9 954 1.0 1,038 1.6 
136 Other joint disorders not classified elsewhere 12,082 2.7 2,745 1.9 2,491 2.4 1,701 3.6 3,872 4.0 1,273 1.9 
137 Systemic connective tissue disorders 42,791 9.4 13,179 9.3 10,144 9.9 3,764 7.9 9,183 9.4 6,521 9.8 
138 Systemic lupus erythematosus 3,381 0.7 1,037 0.7 667 0.6 288 0.6 707 0.7 682 1.0 
139 Dermatopolymyositis 1,136 0.2 298 0.2 284 0.3 108 0.2 292 0.3 154 0.2 
140 Systemic sclerosis 1,678 0.4 444 0.3 480 0.5 165 0.3 336 0.3 253 0.4 
141 Kyphosis, lordosis  4,252 0.9 1,793 1.3 1,093 1.1 371 0.8 603 0.6 392 0.6 
142 Scoliosis  17,701 3.9 4,796 3.4 4,847 4.7 1,929 4.1 4,077 4.2 2,054 3.1 
143 Spinal osteochondrosis  8,105 1.8 2,654 1.9 1,850 1.8 771 1.6 1,617 1.7 1,213 1.8 
144 Other deforming dorsopathies 23,939 5.3 7,100 5.0 6,090 5.9 2,013 4.2 5,680 5.8 3,057 4.6 
145 Other inflammatory spondylopathies 7,112 1.6 1,758 1.2 1,894 1.8 713 1.5 1,773 1.8 974 1.5 
146 Spondylosis 62,116 13.6 18,008 12.7 12,446 12.1 7,784 16.4 16,453 16.9 7,425 11.2 
147 
Other spondylopathies and spondylopathies in 
diseases classified elsewhere 
51,160 11.2 18,096 12.8 10,711 10.4 2,974 6.3 11,861 12.2 7,518 11.3 
148 Cervical disc disorders 11,483 2.5 2,947 2.1 2,797 2.7 820 1.7 3,490 3.6 1,430 2.2 
149 Other intervertebral disc disorders  40,324 8.9 10,139 7.2 9,615 9.4 3,156 6.6 12,431 12.7 4,982 7.5 
150 Other dorsopathies, not classified elsewhere 7,296 1.6 1,049 0.7 2,724 2.7 568 1.2 2,452 2.5 503 0.8 
151 Dorsalgia 41,051 9.0 12,096 8.6 7,384 7.2 4,862 10.2 11,322 11.6 5,389 8.1 
152 Soft tissue disorders 13,534 3.0 3,746 2.7 2,519 2.5 1,131 2.4 3,974 4.1 2,164 3.3 
153 Synovitis and tenosynovitis  19,148 4.2 4,402 3.1 5,547 5.4 1,766 3.7 4,483 4.6 2,950 4.4 
154 Disorders of synovium and tendon 19,708 4.3 5,067 3.6 5,732 5.6 2,057 4.3 4,298 4.4 2,553 3.8 
155 
Soft tissue disorders related to use, overuse and 
pressure 
11,102 2.4 1,672 1.2 4,714 4.6 1,259 2.6 2,431 2.5 1,026 1.5 
156 Fibroblastic disorders 43,600 9.6 11,032 7.8 12,697 12.4 3,906 8.2 10,217 10.5 5,749 8.7 
157 Shoulder lesions  58,073 12.7 11,747 8.3 16,017 15.6 6,008 12.6 16,493 16.9 7,808 11.7 
158 Enthesopathies of lower limb, excluding foot 11,197 2.5 3,458 2.4 2,633 2.6 1,032 2.2 2,885 3.0 1,189 1.8 
159 Other enthesopathies 10,508 2.3 3,288 2.3 2,382 2.3 972 2.0 2,701 2.8 1,165 1.8 
160 Rheumatism, unspecified 6,885 1.5 2,620 1.9 880 0.9 597 1.3 1,252 1.3 1,536 2.3 
161 Myalgia  10,217 2.2 3,031 2.1 2,118 2.1 867 1.8 2,265 2.3 1,935 2.9 
162 
Other soft tissue disorders not classified 
elsewhere 
7,959 1.7 1,635 1.2 3,038 3.0 616 1.3 1,842 1.9 828 1.2 
163 
Other soft tissue disorders not classified 
elsewhere: pain in limb 
22,259 4.9 5,336 3.8 4,355 4.2 2,036 4.3 7,987 8.2 2,544 3.8 
164 Fibromyalgia 3,411 0.7 1,371 1.0 435 0.4 232 0.5 464 0.5 908 1.4 
165 Osteoporosis c 158,613 34.8 43,656 30.9 37,984 37.0 14,967 31.5 46,853 48.0 15,153 22.8 
166 Osteoporosis in diseases classified elsewhere  970 0.2 149 0.1 95 0.1 77 0.2 310 0.3 339 0.5 
167 
Adult osteomalacia and other disorders of bone 
density and structure 
43,110 9.5 3,864 2.7 15,874 15.5 5,788 12.2 13,470 13.8 4,114 6.2 
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168 Disorders of continuity of bone 1,874 0.4 623 0.4 362 0.4 286 0.6 302 0.3 301 0.5 
169 Other osteopathies 23,933 5.3 4,669 3.3 3,922 3.8 1,433 3.0 11,476 11.8 2,434 3.7 
170 
Other disorders of the musculoskeletal system 
and connective tissue 
29,935 6.6 7,758 5.5 6,133 6.0 2,222 4.7 8,507 8.7 5,314 8.0 
 N – Diseases of the genitourinary system 20,288 4.5 5,575 3.9 6,341 6.2 1,881 4.0 4,097 4.2 2,394 3.6 
171 Chronic renal failure (CRF) c 20,288 4.5 5,575 3.9 6,341 6.2 1,881 4.0 4,097 4.2 2,394 3.6 
 
Q – Congenital malformations, deformations 
and chromosomal abnormalities 
125,474 27.5 37,408 26.5 28,375 27.6 13,734 28.9 27,645 28.3 18,311 27.6 
172 
Congenital malformations: of the nervous, 
circulatory and respiratory systems, cleft palate 
and cleft lip, urinary tract, bones and muscles, 
other and chromosomal abnormalities not 
classified elsewhere 
85,936 18.9 24,388 17.3 20,306 19.8 8,916 18.7 19,895 20.4 12,432 18.7 
173 
Congenital malformations of eye, ear, face and 
neck 
19,809 4.3 6,631 4.7 3,825 3.7 2,357 5.0 3,820 3.9 3,175 4.8 
174 
Other congenital malformations of the digestive 
system 
6,547 1.4 2,352 1.7 1,199 1.2 903 1.9 1,197 1.2 896 1.3 
175 Congenital malformations of the sexual organs  16,206 3.6 4,953 3.5 3,677 3.6 1,985 4.2 3,331 3.4 2,260 3.4 
 F – Mental and behavioural disorders 686,616 150.7 201,726 142.8 157,826 153.8 67,032 140.9 160,240 164.2 99,791 150.2 
176 Dementia c 37,022 8.1 12,687 9.0 7,414 7.2 3,169 6.7 8,943 9.2 4,809 7.2 
177 
Organic, including symptomatic, mental 
disorders 
26,792 5.9 8,801 6.2 6,139 6.0 2,304 4.8 6,096 6.2 3,451 5.2 
178 
Mental and behavioural disorders due to use of 
alcohol 
59,965 13.2 21,877 15.5 11,800 11.5 5,030 10.6 12,402 12.7 8,857 13.3 
179 
Mental and behavioural disorders due to  use of 
psychoactive substances  
54,428 11.9 21,498 15.2 5,786 5.6 5,674 11.9 16,081 16.5 5,388 8.1 
180 Schizophrenia c 29,763 6.5 11,189 7.9 5,954 5.8 2,501 5.3 5,983 6.1 4,135 6.2 
181 Schizotypal and delusional disorders 39,979 8.8 15,994 11.3 7,014 6.8 2,963 6.2 8,243 8.4 5,765 8.7 
182 Bipolar affective disorder c 22,763 5.0 7,215 5.1 5,998 5.8 1,792 3.8 4,730 4.8 3,028 4.6 
183 Depression c 456,529 100.2 119,538 84.6 116,812 113.8 46,429 97.6 108,337 111.0 65,412 98.4 
184 Mood (affective) disorders  6,920 1.5 2,154 1.5 1,436 1.4 646 1.4 1,447 1.5 1,237 1.9 
185 Phobic anxiety disorders 14,481 3.2 4,434 3.1 3,752 3.7 1,062 2.2 3,454 3.5 1,780 2.7 
186 Other anxiety disorders 38,270 8.4 14,053 9.9 7,008 6.8 2,609 5.5 8,283 8.5 6,317 9.5 
187 Obsessive compulsive disorder (OCD) c 10,089 2.2 3,326 2.4 2,443 2.4 855 1.8 1,994 2.0 1,472 2.2 
188 Post-traumatic stress disorder 16,201 3.6 4,722 3.3 4,110 4.0 1,242 2.6 3,491 3.6 2,636 4.0 
189 
Reactions to severe stress and adjustment 
disorders 
62,274 13.7 18,318 13.0 10,845 10.6 4,337 9.1 16,878 17.3 11,896 17.9 
190 
Dissociative (conversion) disorders, 
somatoform disorders and other neurotic 
disorders 
21,617 4.7 8,201 5.8 4,501 4.4 1,656 3.5 4,145 4.2 3,114 4.7 
191 Eating disorders 7,643 1.7 2,951 2.1 1,567 1.5 585 1.2 1,626 1.7 914 1.4 
192 
Behavioural syndromes associated with 
physiological disturbances and physical factors 
6,110 1.3 2,720 1.9 992 1.0 482 1.0 894 0.9 1,022 1.5 
193 Emotionally unstable personality disorder 22,134 4.9 6,722 4.8 4,053 3.9 2,014 4.2 5,232 5.4 4,114 6.2 
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c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Note that the region is the origin of the patients’ home resident region. Conditions marked ‘A’ overlap 
with other conditions and are thus not counted twice [1].  
194 Specific personality disorders 50,903 11.2 15,792 11.2 10,029 9.8 4,834 10.2 12,207 12.5 8,042 12.1 
195 Disorders of adult personality and behaviour 17,727 3.9 5,043 3.6 4,454 4.3 2,021 4.2 4,088 4.2 2,121 3.2 
196 Mental retardation 13,908 3.1 3,897 2.8 2,935 2.9 1,381 2.9 3,642 3.7 2,053 3.1 
197 Disorders of psychological development 10,020 2.2 2,744 1.9 2,863 2.8 1,140 2.4 1,793 1.8 1,479 2.2 
198 Hyperkinetic disorders (ADHD) c 43,326 9.5 11,313 8.0 13,334 13.0 4,645 9.8 6,976 7.1 7,057 10.6 
199 
Behavioural and emotional disorders with onset 
usually occurring in childhood and adolescence 
39,990 8.8 14,764 10.4 5,228 5.1 4,832 10.2 9,794 10.0 5,372 8.1 
 Having one or more chronic conditions  2,993,677 657.2 902,043 638.4 680,603 663.1 312,637 657.3 660,694 677.1 437,701 658.6 
              
 Depression medicine c    ** 531,816 116.7 145,284 102.8 131,236 127.9 54,446 114.5 124,745 127.8 76,105 114.5 
 Antipsychotic medicine c    ** 139,396 30.6 39,759 28.1 30,059 29.3 14,074 29.6 34,076 34.9 21,428 32.2 
 Indication prescribed anxiety medicine c    ** 103,081 22.6 29,210 20.7 25,062 24.4 11,030 23.2 21,944 22.5 15,834 23.8 
 Heart failure medication c    ** 7,571 1.7 2,725 1.9 1,877 1.8 642 1.3 1,179 1.2 1,148 1.7 
 Ischaemic heart medication c    ** 129,708 28.5 38,486 27.2 32,378 31.5 13,448 28.3 26,532 27.2 18,865 28.4 
 All of the five types of medicine above  690,456 151.6 194,511 137.7 166,757 162.5 70,836 148.9 157,917 161.8 100,435 151.1 
              
 Others: arthrosis combined (M15-M19)  338,465 74.3 99,856 70.7 79,043 77.0 35,706 75.1 76,223 78.1 47,637 71.7 




Supplementary Material 5: Regional differences not standardised – for all 199 conditions 
 
Table 7. N and prevalence of conditions and medicine for Denmark and the five regions – at 1 January 2013  
Nr Condition Denmark 





























B –  Viral hepatitis and human 
immunodeficiency virus [HIV] disease 
8,813 1.9 4,044 2.9 1,862 1.8 485 1.0 1,465 1.5 957 1.4 
1 Chronic viral hepatitis  4,584 1.0 1,633 1.2 1,263 1.2 286 0.6 944 1.0 458 0.7 
2 Human immunodeficiency virus [HIV] disease 4,229 0.9 2,411 1.7 599 0.6 199 0.4 521 0.5 499 0.8 
 C – Malignant neoplasms 229,331 50.3 69,152 48.9 50,351 49.1 22,541 47.4 49,606 50.8 37,681 56.7 
3 
Malignant neoplasms of other and unspecified 
localisations 
20,557 4.5 7,605 5.4 4,132 4.0 2,123 4.5 3,312 3.4 3,385 5.1 
4 Malignant neoplasms of digestive organs 4,839 1.1 1,586 1.1 975 0.9 469 1.0 981 1.0 828 1.2 
5 Malignant neoplasm of colon 18,826 4.1 6,007 4.3 3,634 3.5 1,916 4.0 3,909 4.0 3,360 5.1 
6 
Malignant neoplasms of rectosigmoid junction, 
rectum, anus and anal canal 
10,680 2.3 3,035 2.1 2,202 2.1 1,246 2.6 2,361 2.4 1,836 2.8 
7 Malignant neoplasm of bronchus and lung 14,762 3.2 2,942 2.1 5,425 5.3 1,140 2.4 3,248 3.3 2,007 3.0 
8 Malignant melanoma of skin 19,636 4.3 7,128 5.0 3,373 3.3 1,437 3.0 4,355 4.5 3,343 5.0 
9 Other malignant neoplasms of skin 15,597 3.4 4,702 3.3 3,318 3.2 983 2.1 4,241 4.3 2,353 3.5 
10 Malignant neoplasm of breast 50,687 11.1 15,642 11.1 10,933 10.7 4,891 10.3 11,692 12.0 7,529 11.3 
11 Malignant neoplasms of female genital organs 7,245 1.6 2,114 1.5 1,159 1.1 655 1.4 1,366 1.4 1,951 2.9 
12 
Malignant neoplasm of cervix uteri, corpus 
uteri and part unspecified 
11,608 2.5 3,285 2.3 2,159 2.1 1,233 2.6 2,372 2.4 2,559 3.9 
13 Malignant tumour of male genitalia 5,194 1.1 1,689 1.2 1,114 1.1 520 1.1 1,067 1.1 804 1.2 
14 Malignant neoplasm of prostate 26,697 5.9 7,432 5.3 5,639 5.5 3,470 7.3 5,703 5.8 4,453 6.7 
15 Malignant neoplasms of urinary tract 10,319 2.3 2,657 1.9 2,309 2.2 1,340 2.8 2,262 2.3 1,751 2.6 
16 Brain cancer c   15,310 3.4 4,942 3.5 3,097 3.0 1,593 3.3 2,803 2.9 2,875 4.3 
17 
Malignant neoplasms of ill-defined, secondary 
and unspecified sites, and of independent 
(primary) multiple sites 
25,619 5.6 5,730 4.1 9,042 8.8 2,603 5.5 5,033 5.2 3,211 4.8 
18 
Malignant neoplasms, stated or presumed to be 
primary, of lymphoid, haematopoietic and 
related tissue 
19,712 4.3 5,828 4.1 4,340 4.2 1,821 3.8 4,778 4.9 2,945 4.4 
 
D – In situ and benign neoplasms, and  
neoplasms of uncertain or unknown 
behaviour and diseases of the blood and 
blood-forming organs and certain disorders 
116,560 25.6 33,869 24.0 28,543 27.8 10,816 22.7 25,252 25.9 18,080 27.2 
 
26 
involving the immune mechanism 
19 In situ neoplasms 19,810 4.3 6,050 4.3 3,809 3.7 2,117 4.5 4,698 4.8 3,136 4.7 
20 Haemolytic anaemias   3,055 0.7 1,095 0.8 725 0.7 239 0.5 609 0.6 387 0.6 
21 Aplastic and other anaemias   14,918 3.3 5,121 3.6 2,898 2.8 1,543 3.2 2,704 2.8 2,652 4.0 
22 Other anaemias   46,613 10.2 12,889 9.1 10,509 10.2 4,458 9.4 11,057 11.3 7,700 11.6 
23 
Coagulation defects, purpura and other 
haemorrhagic conditions 
25,376 5.6 6,958 4.9 8,745 8.5 1,734 3.6 4,364 4.5 3,575 5.4 
24 
Other diseases of blood and blood-forming 
organs 
8,896 2.0 2,656 1.9 2,118 2.1 729 1.5 2,022 2.1 1,371 2.1 
25 
Certain disorders involving the immune 
mechanism 
7,660 1.7 2,049 1.5 1,835 1.8 900 1.9 1,765 1.8 1,111 1.7 
 
E – Endocrine, nutritional and metabolic 
diseases  
877,433 192.6 239,987 169.8 198,343 193.3 99,109 208.4 203,465 208.5 136,529 205.4 
26 Diseases of the thyroid c 131,908 29.0 40,033 28.3 27,603 26.9 11,705 24.6 29,898 30.6 22,669 34.1 
27 Thyrotoxicosis c 41,374 9.1 11,122 7.9 9,603 9.4 5,867 12.3 10,023 10.3 4,759 7.2 
28 Diabetes type 1 c 23,062 5.1 6,493 4.6 5,484 5.3 2,487 5.2 5,289 5.4 3,309 5.0 
29 Diabetes type 2 c 242,177 53.2 65,552 46.4 54,087 52.7 26,462 55.6 57,200 58.6 38,876 58.5 
30 Diabetes others c 1,117 0.2 328 0.2 224 0.2 90 0.2 320 0.3 155 0.2 
31 Disorders of other endocrine glands 28,650 6.3 8,314 5.9 7,847 7.6 2,035 4.3 6,974 7.1 3,480 5.2 
32 Metabolic disorders 23,690 5.2 6,904 4.9 5,973 5.8 1,920 4.0 5,565 5.7 3,328 5.0 
33 
Disturbances in lipoprotein circulation and 
other lipids c  
652,242 143.2 171,435 121.3 150,276 146.4 77,816 163.6 151,740 155.5 100,975 151.9 
34 Cystic fibrosis c 947 0.2 493 0.3 121 0.1 57 0.1 126 0.1 150 0.2 
 G – Diseases of the nervous system 561,054 123.2 153,150 108.4 131,330 128.0 56,245 118.3 131,490 134.7 88,839 133.7 
35 
Inflammatory diseases of the central nervous 
system 
7,642 1.7 2,432 1.7 1,721 1.7 666 1.4 1,677 1.7 1,146 1.7 
36 
Systemic atrophies primarily affecting the 
central nervous system and other degenerative 
diseases  
10,401 2.3 4,189 3.0 1,688 1.6 610 1.3 1,853 1.9 2,061 3.1 
37 Parkinson’s disease c 57,583 12.6 14,650 10.4 13,320 13.0 6,874 14.5 14,197 14.5 8,542 12.9 
38 Extrapyramidal and movement disorders 10,837 2.4 3,143 2.2 2,902 2.8 962 2.0 2,393 2.5 1,437 2.2 
39 Sclerosis  13,284 2.9 3,882 2.7 3,024 2.9 1,201 2.5 3,059 3.1 2,118 3.2 
40 
Demyelinating diseases of the central nervous 
system  
4,571 1.0 1,168 0.8 1,000 1.0 514 1.1 1,060 1.1 829 1.2 
41 Epilepsy c 61,695 13.5 15,995 11.3 15,637 15.2 6,399 13.5 14,133 14.5 9,531 14.3 
42 Migraine c 149,866 32.9 44,497 31.5 32,727 31.9 15,416 32.4 33,362 34.2 23,864 35.9 
43 Other headache syndromes 16,469 3.6 5,914 4.2 3,279 3.2 1,216 2.6 3,858 4.0 2,202 3.3 
44 
Transient cerebral ischaemic attacks and related 
syndromes and vascular syndromes of brain in 
cerebrovascular diseases 
43,977 9.7 11,843 8.4 10,192 9.9 5,230 11.0 9,949 10.2 6,763 10.2 
45 Sleep disorders 36,806 8.1 10,314 7.3 9,134 8.9 4,128 8.7 7,564 7.8 5,666 8.5 
46 
Disorders of trigeminal nerve and facial nerve 
disorders  




Disorders of other cranial nerves, cranial nerve 
disorders in diseases classified elsewhere, nerve 
root and plexus disorders and nerve root and 
plexus compressions in diseases classified 
elsewhere   
12,429 2.7 3,674 2.6 2,589 2.5 938 2.0 3,622 3.7 1,606 2.4 
48 Mononeuropathies of upper limb   122,395 26.9 25,143 17.8 34,452 33.6 12,217 25.7 34,264 35.1 16,319 24.6 
49 
Mononeuropathies of lower limb, other 
mononeuropathies and mononeuropathy in 
diseases classified elsewhere 
18,627 4.1 4,388 3.1 5,039 4.9 1,593 3.3 5,220 5.3 2,387 3.6 
50 
Polyneuropathies and other disorders of the 
peripheral nervous system 
30,289 6.6 8,420 6.0 7,824 7.6 2,589 5.4 8,023 8.2 3,433 5.2 
51 Diseases of myoneural junction and muscle 5,758 1.3 1,819 1.3 1,295 1.3 551 1.2 1,191 1.2 902 1.4 
52 Cerebral palsy and other paralytic syndromes 14,410 3.2 3,883 2.7 3,459 3.4 1,392 2.9 3,224 3.3 2,452 3.7 
53 Other disorders of the nervous system 44,394 9.7 13,980 9.9 5,367 5.2 2,311 4.9 6,868 7.0 15,868 23.9 
 
H – Diseases of the eye and adnexa and 
diseases of the ear and mastoid process 
448,176 98.4 133,445 94.4 98,443 95.9 48,753 102.5 101,774 104.3 65,761 99.0 
54 Disorders of eyelid, lacrimal system and orbit 13,191 2.9 3,212 2.3 3,177 3.1 1,863 3.9 3,611 3.7 1,328 2.0 
55 Corneal scars and opacities 2,173 0.5 313 0.2 792 0.8 319 0.7 499 0.5 250 0.4 
56 Other disorders of cornea 9,473 2.1 2,165 1.5 3,266 3.2 1,141 2.4 1,836 1.9 1,065 1.6 
57 Diseases of the eye lens (cataracts)  68,009 14.9 21,699 15.4 15,846 15.4 6,126 12.9 14,965 15.3 9,373 14.1 
58 Disorders of the choroid and retina 1,900 0.4 515 0.4 336 0.3 266 0.6 477 0.5 306 0.5 
59 Retinal vascular occlusions 10,358 2.3 3,142 2.2 2,276 2.2 1,019 2.1 2,348 2.4 1,573 2.4 
60 Other retinal disorders 68,485 15.0 20,538 14.5 15,650 15.2 6,883 14.5 15,236 15.6 10,178 15.3 
61 
Retinal disorders in diseases classified 
elsewhere 
19,279 4.2 2,925 2.1 8,990 8.8 1,368 2.9 3,277 3.4 2,719 4.1 
62 Glaucoma c 67,310 14.8 19,617 13.9 17,335 16.9 7,102 14.9 14,078 14.4 9,178 13.8 
63 Disorders of the vitreous body and globe  7,572 1.7 2,080 1.5 2,108 2.1 1,149 2.4 1,443 1.5 792 1.2 
64 Disorders of optic nerve and visual pathways 6,184 1.4 1,982 1.4 1,215 1.2 789 1.7 1,320 1.4 878 1.3 
65 
Disorders of ocular muscles, binocular 
movement, accommodation and refraction 
18,247 4.0 6,267 4.4 3,699 3.6 2,289 4.8 3,433 3.5 2,559 3.9 
66 Visual disturbances   22,232 4.9 5,504 3.9 5,474 5.3 3,848 8.1 4,656 4.8 2,750 4.1 
67 Blindness and partial sight  6,614 1.5 2,553 1.8 1,164 1.1 680 1.4 1,281 1.3 936 1.4 
68 
Nystagmus and other irregular eye movements 
and other disorders of eye and adnexa 
11,133 2.4 6,120 4.3 1,782 1.7 884 1.9 1,311 1.3 1,036 1.6 
69 Otosclerosis  10,360 2.3 3,255 2.3 1,890 1.8 1,069 2.2 2,395 2.5 1,751 2.6 
70 Ménière’s disease c 10,003 2.2 2,725 1.9 1,865 1.8 928 2.0 2,703 2.8 1,782 2.7 
71 Other diseases of the inner ear  29,865 6.6 4,532 3.2 4,406 4.3 6,192 13.0 10,262 10.5 4,473 6.7 
72 Conductive and sensorineural hearing loss 43,238 9.5 15,176 10.7 9,246 9.0 4,635 9.7 8,202 8.4 5,979 9.0 
73 
Other hearing loss and other disorders of ear not 
classified elsewhere  
8,306 1.8 2,184 1.5 1,276 1.2 788 1.7 2,754 2.8 1,304 2.0 
74 Presbycusis (age-related hearing loss)  80,659 17.7 24,210 17.1 11,428 11.1 11,600 24.4 21,762 22.3 11,659 17.5 
75 Hearing loss, unspecified  87,806 19.3 27,525 19.5 17,137 16.7 7,983 16.8 20,069 20.6 15,092 22.7 
76 Tinnitus 40,124 8.8 11,866 8.4 5,470 5.3 6,352 13.4 10,352 10.6 6,084 9.2 
 
28 
77 Other specified disorders of ear 20,537 4.5 2,949 2.1 2,396 2.3 2,109 4.4 7,285 7.5 5,798 8.7 
 I – Diseases of the circulatory system 1,254,427 275.4 344,337 243.7 276,838 269.7 141,084 296.6 292,077 299.3 200,091 301.1 
78 Aortic and mitral valve disease c 30,123 6.6 6,396 4.5 8,155 7.9 3,068 6.5 8,031 8.2 4,473 6.7 
79 Hypertensive diseases c 1,060,046 232.7 288,242 204.0 231,815 225.9 122,685 257.9 247,358 253.5 169,946 255.7 
80 Heart failure c 37,540 8.2 13,100 9.3 7,265 7.1 2,836 6.0 7,761 8.0 6,578 9.9 
80A Ischaemic heart diseases 139,173 30.6 38,791 27.5 33,305 32.4 13,891 29.2 28,812 29.5 24,374 36.7 
81       Angina pectoris 78,476 17.2 21,093 14.9 22,162 21.6 8,345 17.5 15,228 15.6 11,648 17.5 
82 
      Acute myocardial infarction and  
      subsequent myocardial infarction 
36,654 8.0 10,326 7.3 7,936 7.7 3,499 7.4 8,130 8.3 6,763 10.2 
83       AMI complex/other  2,969 0.7 1,007 0.7 295 0.3 132 0.3 416 0.4 1,119 1.7 
84       Chronic ischaemic heart disease 84,592 18.6 23,731 16.8 18,166 17.7 8,139 17.1 18,070 18.5 16,486 24.8 
85 
Pulmonary heart disease and diseases of 
pulmonary circulation 
15,352 3.4 5,015 3.5 2,928 2.9 1,262 2.7 3,613 3.7 2,534 3.8 
86 Acute pericarditis  5,563 1.2 1,797 1.3 1,111 1.1 448 0.9 1,281 1.3 926 1.4 
87 Other forms of heart disease 8,119 1.8 2,548 1.8 1,617 1.6 720 1.5 1,901 1.9 1,333 2.0 
88 Atrioventricular and left bundle branch block 14,604 3.2 3,926 2.8 3,489 3.4 1,530 3.2 3,351 3.4 2,308 3.5 
89 Other conduction disorders 11,823 2.6 3,605 2.6 2,365 2.3 1,097 2.3 2,583 2.6 2,173 3.3 
90 Paroxysmal tachycardia 39,510 8.7 11,142 7.9 8,978 8.7 4,207 8.8 7,686 7.9 7,497 11.3 
91 Atrial fibrillation and flutter 112,342 24.7 32,348 22.9 24,832 24.2 12,166 25.6 25,123 25.7 17,873 26.9 
92 Other cardiac arrhythmias 34,418 7.6 9,354 6.6 8,369 8.2 3,091 6.5 8,087 8.3 5,517 8.3 
93 
Complications and ill-defined descriptions of 
heart disease and other heart disorders in 
diseases classified elsewhere 
7,337 1.6 2,827 2.0 2,083 2.0 330 0.7 1,366 1.4 731 1.1 
94 Stroke 72,606 15.9 21,256 15.0 16,148 15.7 6,401 13.5 16,263 16.7 12,538 18.9 
95 Cerebrovascular diseases 17,308 3.8 5,546 3.9 3,364 3.3 1,665 3.5 4,667 4.8 2,066 3.1 
96 Sequelae of cerebrovascular disease 50,952 11.2 14,089 10.0 9,755 9.5 4,942 10.4 13,407 13.7 8,759 13.2 
97 Atherosclerosis  32,064 7.0 7,857 5.6 6,054 5.9 2,918 6.1 8,752 9.0 6,483 9.8 
98 Aortic aneurysm and aortic dissection  10,296 2.3 2,886 2.0 2,470 2.4 896 1.9 2,444 2.5 1,600 2.4 
99 Diseases of arteries, arterioles and capillaries 11,830 2.6 4,007 2.8 2,696 2.6 892 1.9 2,629 2.7 1,606 2.4 
100 Other peripheral vascular diseases 28,508 6.3 7,382 5.2 6,519 6.4 2,999 6.3 7,840 8.0 3,768 5.7 
101 
Phlebitis, thrombosis of the portal vein and 
others   
37,388 8.2 12,242 8.7 6,238 6.1 3,997 8.4 8,139 8.3 6,772 10.2 
102 Varicose veins of lower extremities 23,530 5.2 4,919 3.5 7,215 7.0 3,093 6.5 7,179 7.4 1,124 1.7 
103 Haemorrhoids c 74,285 16.3 18,906 13.4 18,066 17.6 7,760 16.3 18,091 18.5 11,462 17.2 
104 
Oesophageal varices (chronic), varicose veins 
of other sites, other disorders of veins, non-
specific lymphadenitis, other non-infective 
disorders of lymphatic vessels and lymph nodes 
and other and unspecified disorders of the 
circulatory system 
15,194 3.3 4,137 2.9 2,900 2.8 1,209 2.5 3,119 3.2 3,829 5.8 
 J – Diseases of the respiratory system 1,210,598 265.7 379,715 268.7 266,681 259.8 124,207 261.1 261,003 267.5 178,992 269.3 
 
29 
105 Respiratory allergy c 841,685 184.8 272,801 193.1 186,358 181.6 84,493 177.6 175,290 179.6 122,743 184.7 
105A Chronic lower respiratory diseases c 418,120 91.8 130,170 92.1 87,172 84.9 42,561 89.5 95,101 97.5 63,116 95.0 
106 
  Bronchitis, not specified as acute 
   or chronic, simple and  
  mucopurulent chronic bronchitis  
  and unspecified chronic bronchitis 
12,790 2.8 3,464 2.5 2,579 2.5 1,312 2.8 3,793 3.9 1,642 2.5 
107    Emphysema 5,557 1.2 1,322 0.9 1,525 1.5 556 1.2 1,036 1.1 1,118 1.7 
108 Chronic obstructive lung disease (COPD) c 216,184 47.5 60,978 43.2 48,685 47.4 23,279 48.9 50,412 51.7 32,830 49.4 
109 Asthma, status asthmaticus c 361,129 79.3 107,743 76.2 81,142 79.1 39,243 82.5 79,483 81.5 53,518 80.5 
110    Bronchiectasis 4,362 1.0 1,065 0.8 1,572 1.5 506 1.1 522 0.5 697 1.0 
111 Other diseases of the respiratory system 21,993 4.8 6,414 4.5 4,727 4.6 1,743 3.7 5,755 5.9 3,354 5.0 
 K –  Diseases of the digestive system 329,337 72.3 95,452 67.5 71,490 69.7 34,486 72.5 74,822 76.7 53,087 79.9 
112 Ulcers c 157,379 34.5 50,062 35.4 31,326 30.5 16,027 33.7 32,238 33.0 27,726 41.7 
113 Inguinal hernia  25,032 5.5 6,533 4.6 5,638 5.5 3,050 6.4 5,901 6.0 3,910 5.9 
114 Ventral hernia 7,941 1.7 1,973 1.4 1,792 1.7 936 2.0 1,917 2.0 1,323 2.0 
115 Crohn’s diease  18,913 4.2 6,242 4.4 4,145 4.0 1,728 3.6 3,673 3.8 3,125 4.7 
116 Ulcerative colitis  29,538 6.5 8,224 5.8 7,077 6.9 2,812 5.9 6,789 7.0 4,636 7.0 
117 Other non-infective gastroenteritis and colitis 20,844 4.6 5,611 4.0 4,187 4.1 2,059 4.3 5,182 5.3 3,805 5.7 
118 Irritable bowel syndrome (IBS)  37,593 8.3 9,025 6.4 7,292 7.1 4,739 10.0 10,897 11.2 5,640 8.5 
119 Other functional intestinal disorders 51,933 11.4 12,849 9.1 15,297 14.9 4,937 10.4 12,689 13.0 6,161 9.3 
120 Diseases of liver, biliary tract and pancreas  26,956 5.9 8,753 6.2 5,284 5.1 2,359 5.0 5,901 6.0 4,659 7.0 
 
L – Diseases of the skin and subcutaneous 
tissue 
65,469 14.4 22,064 15.6 14,781 14.4 6,049 12.7 13,003 13.3 9,572 14.4 
121 Psoriasis c 65,469 14.4 22,064 15.6 14,781 14.4 6,049 12.7 13,003 13.3 9,572 14.4 
 
M – Diseases of the musculoskeletal system 
and connective tissue 
1,032,808 226.7 276,332 195.6 243,447 237.2 106,406 223.7 257,765 264.2 148,858 224.0 
122 Infectious arthropathies 9,402 2.1 3,134 2.2 2,020 2.0 915 1.9 1,990 2.0 1,343 2.0 
122A 
Inflammatory polyarthropathies and ankylosing 
spondylitis c 
165,944 36.4 50,126 35.5 34,011 33.1 16,350 34.4 37,418 38.3 28,039 42.2 
123       Rheumatoid arthritis c 77,345 17.0 24,151 17.1 16,308 15.9 7,349 15.5 16,340 16.7 13,197 19.9 
124 
      Inflammatory polyarthropathies 
       – except rheumatoid arthritis c 
115,945 25.5 34,119 24.1 23,267 22.7 11,683 24.6 27,343 28.0 19,533 29.4 
125 Polyarthrosis [arthrosis] 16,935 3.7 4,745 3.4 4,318 4.2 1,230 2.6 4,457 4.6 2,185 3.3 
126 Coxarthrosis [arthrosis of hip] 104,115 22.9 28,367 20.1 22,599 22.0 11,181 23.5 25,027 25.6 16,941 25.5 
127 Gonarthrosis [arthrosis of knee] 178,811 39.3 48,950 34.6 39,447 38.4 21,693 45.6 41,112 42.1 27,609 41.5 
128 
Arthrosis of first carpometacarpal joint and 
other arthrosis 
91,101 20.0 25,293 17.9 22,046 21.5 8,269 17.4 22,384 22.9 13,109 19.7 
129 Acquired deformities of fingers and toes  55,730 12.2 14,429 10.2 13,728 13.4 4,383 9.2 14,411 14.8 8,779 13.2 
130 Other acquired deformities of limbs  20,584 4.5 4,062 2.9 6,087 5.9 2,066 4.3 6,160 6.3 2,209 3.3 
131 Disorders of patella (knee cap) 38,999 8.6 9,796 6.9 12,163 11.9 4,985 10.5 7,892 8.1 4,163 6.3 




Derangement of meniscus due to old tear or 
injury 
36,374 8.0 11,579 8.2 7,020 6.8 3,183 6.7 8,746 9.0 5,846 8.8 
134 Internal derangement of knee, unspecified 28,206 6.2 6,794 4.8 8,290 8.1 2,150 4.5 7,823 8.0 3,149 4.7 
135 Other specific joint derangements 5,923 1.3 2,395 1.7 1,203 1.2 429 0.9 917 0.9 979 1.5 
136 Other joint disorders not classified elsewhere 12,043 2.6 2,721 1.9 2,476 2.4 1,694 3.6 3,873 4.0 1,279 1.9 
137 Systemic connective tissue disorders 42,631 9.4 12,588 8.9 9,881 9.6 3,871 8.1 9,445 9.7 6,846 10.3 
138 Systemic lupus erythematosus 3,376 0.7 1,009 0.7 656 0.6 283 0.6 714 0.7 714 1.1 
139 Dermatopolymyositis 1,137 0.2 283 0.2 277 0.3 112 0.2 302 0.3 163 0.2 
140 Systemic sclerosis 1,675 0.4 420 0.3 468 0.5 168 0.4 347 0.4 272 0.4 
141 Kyphosis, lordosis  4,160 0.9 1,692 1.2 1,085 1.1 369 0.8 605 0.6 409 0.6 
142 Scoliosis  17,686 3.9 4,904 3.5 4,883 4.8 1,899 4.0 4,017 4.1 1,983 3.0 
143 Spinal osteochondrosis  8,034 1.8 2,537 1.8 1,837 1.8 773 1.6 1,622 1.7 1,265 1.9 
144 Other deforming dorsopathies 23,756 5.2 6,633 4.7 5,970 5.8 2,070 4.4 5,847 6.0 3,236 4.9 
145 Other inflammatory spondylopathies 7,086 1.6 1,687 1.2 1,873 1.8 721 1.5 1,787 1.8 1,018 1.5 
146 Spondylosis 61,999 13.6 16,350 11.6 12,159 11.8 8,174 17.2 17,195 17.6 8,121 12.2 
147 
Other spondylopathies and spondylopathies in 
diseases classified elsewhere 
50,805 11.2 16,496 11.7 10,367 10.1 3,149 6.6 12,546 12.9 8,247 12.4 
148 Cervical disc disorders 11,476 2.5 2,854 2.0 2,760 2.7 815 1.7 3,550 3.6 1,497 2.3 
149 Other intervertebral disc disorders  40,161 8.8 9,898 7.0 9,480 9.2 3,156 6.6 12,547 12.9 5,080 7.6 
150 Other dorsopathies not classified elsewhere 7,246 1.6 1,042 0.7 2,688 2.6 564 1.2 2,444 2.5 508 0.8 
151 Dorsalgia 40,780 9.0 11,745 8.3 7,301 7.1 4,868 10.2 11,339 11.6 5,527 8.3 
152 Soft tissue disorders 13,422 2.9 3,765 2.7 2,500 2.4 1,120 2.4 3,925 4.0 2,112 3.2 
153 Synovitis and tenosynovitis  19,104 4.2 4,331 3.1 5,491 5.4 1,765 3.7 4,546 4.7 2,971 4.5 
154 Disorders of synovium and tendon 19,669 4.3 5,123 3.6 5,748 5.6 2,018 4.2 4,261 4.4 2,519 3.8 
155 
Soft tissue disorders related to use, overuse and 
pressure 
11,090 2.4 1,617 1.1 4,667 4.5 1,280 2.7 2,464 2.5 1,062 1.6 
156 Fibroblastic disorders 43,600 9.6 10,167 7.2 12,435 12.1 4,042 8.5 10,662 10.9 6,294 9.5 
157 Shoulder lesions  58,112 12.8 11,256 8.0 15,853 15.4 6,084 12.8 16,768 17.2 8,151 12.3 
158 Enthesopathies of lower limb, excluding foot 11,223 2.5 3,532 2.5 2,651 2.6 1,010 2.1 2,871 2.9 1,159 1.7 
159 Other enthesopathies 10,500 2.3 3,269 2.3 2,365 2.3 965 2.0 2,713 2.8 1,188 1.8 
160 Rheumatism, unspecified 6,852 1.5 2,449 1.7 863 0.8 614 1.3 1,284 1.3 1,642 2.5 
161 Myalgia  10,168 2.2 2,884 2.0 2,086 2.0 873 1.8 2,318 2.4 2,007 3.0 
162 
Other soft tissue disorders not classified 
elsewhere 
7,939 1.7 1,575 1.1 3,026 2.9 615 1.3 1,866 1.9 857 1.3 
163 
Other soft tissue disorders not classified 
elsewhere: pain in limb 
22,201 4.9 5,182 3.7 4,314 4.2 2,048 4.3 8,060 8.3 2,597 3.9 
164 Fibromyalgia 3,399 0.7 1,332 0.9 427 0.4 238 0.5 473 0.5 929 1.4 
165 Osteoporosis c 158,813 34.9 40,589 28.7 36,426 35.5 15,785 33.2 49,447 50.7 16,566 24.9 
166 Osteoporosis in diseases classified elsewhere  1,007 0.2 142 0.1 92 0.1 81 0.2 321 0.3 371 0.6 
167 Adult osteomalacia and other disorders of bone 43,271 9.5 3,698 2.6 15,282 14.9 5,913 12.4 13,924 14.3 4,454 6.7 
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density and structure 
168 Disorders of continuity of bone 1,865 0.4 599 0.4 362 0.4 287 0.6 310 0.3 307 0.5 
169 Other osteopathies 24,251 5.3 4,451 3.1 3,859 3.8 1,466 3.1 11,922 12.2 2,553 3.8 
170 
Other disorders of the musculoskeletal system 
and connective tissue 
30,038 6.6 7,685 5.4 6,085 5.9 2,249 4.7 8,640 8.9 5,379 8.1 
 N – Diseases of the genitourinary system 20,162 4.4 4,980 3.5 6,222 6.1 2,021 4.2 4,352 4.5 2,587 3.9 
171 Chronic renal failure (CRF) c 20,162 4.4 4,980 3.5 6,222 6.1 2,021 4.2 4,352 4.5 2,587 3.9 
 
Q – Congenital malformations, deformations 
and chromosomal abnormalities 
124,898 27.4 38,354 27.1 28,360 27.6 13,416 28.2 27,139 27.8 17,629 26.5 
172 
Congenital malformations: of the nervous, 
circulatory and respiratory systems, cleft palate 
and cleft lip, urinary tract, bones and muscles, 
other and chromosomal abnormalities not 
classified elsewhere 
85,534 18.8 25,072 17.7 20,288 19.8 8,718 18.3 19,516 20.0 11,940 18.0 
173 
Congenital malformations of eye, ear, face and 
neck 
19,689 4.3 6,929 4.9 3,847 3.7 2,237 4.7 3,705 3.8 2,971 4.5 
174 
Other congenital malformations of the digestive 
system 
6,481 1.4 2,244 1.6 1,179 1.1 917 1.9 1,217 1.2 924 1.4 
175 Congenital malformations of the sexual organs  16,192 3.6 5,071 3.6 3,678 3.6 1,944 4.1 3,277 3.4 2,222 3.3 
 F – Mental and behavioural disorders 683,194 150.0 197,626 139.9 155,979 152.0 67,510 141.9 161,658 165.7 100,421 151.1 
176 Dementia c 36,803 8.1 11,322 8.0 7,121 6.9 3,489 7.3 9,733 10.0 5,138 7.7 
177 
Organic, including symptomatic, mental 
disorders 
26,430 5.8 8,023 5.7 5,949 5.8 2,417 5.1 6,405 6.6 3,636 5.5 
178 
Mental and behavioural disorders due to use of 
alcohol 
59,143 13.0 20,473 14.5 11,685 11.4 5,128 10.8 12,641 13.0 9,216 13.9 
179 
Mental and behavioural disorders due to  use of 
psychoactive substances  
53,669 11.8 20,878 14.8 5,712 5.6 5,692 12.0 16,096 16.5 5,291 8.0 
180 Schizophrenia c 29,422 6.5 10,902 7.7 5,841 5.7 2,512 5.3 5,999 6.1 4,168 6.3 
181 Schizotypal and delusional disorders 39,694 8.7 15,726 11.1 6,882 6.7 2,984 6.3 8,316 8.5 5,786 8.7 
182 Bipolar affective disorder c 22,669 5.0 6,997 5.0 5,896 5.7 1,806 3.8 4,812 4.9 3,158 4.8 
183 Depression c 454,933 99.9 117,031 82.8 115,169 112.2 46,752 98.3 109,548 112.3 66,433 100.0 
184 Mood (affective) disorders  6,887 1.5 2,107 1.5 1,411 1.4 654 1.4 1,456 1.5 1,259 1.9 
185 Phobic anxiety disorders 14,324 3.1 4,630 3.3 3,706 3.6 1,005 2.1 3,304 3.4 1,679 2.5 
186 Other anxiety disorders 38,079 8.4 14,259 10.1 6,914 6.7 2,548 5.4 8,186 8.4 6,172 9.3 
187 Obsessive compulsive disorder (OCD) c 10,062 2.2 3,543 2.5 2,460 2.4 812 1.7 1,904 2.0 1,343 2.0 
188 Post-traumatic stress disorder 16,055 3.5 4,715 3.3 4,020 3.9 1,213 2.6 3,477 3.6 2,630 4.0 
189 
Reactions to severe stress and adjustment 
disorders 
61,701 13.5 18,761 13.3 10,801 10.5 4,213 8.9 16,556 17.0 11,370 17.1 
190 
Dissociative (conversion) disorders, 
somatoform disorders and other neurotic 
disorders 
21,420 4.7 8,053 5.7 4,442 4.3 1,635 3.4 4,152 4.3 3,138 4.7 
191 Eating disorders 7,751 1.7 3,301 2.3 1,605 1.6 552 1.2 1,512 1.5 781 1.2 
192 
Behavioural syndromes associated with 
physiological disturbances and physical factors 
6,163 1.4 2,876 2.0 995 1.0 460 1.0 858 0.9 974 1.5 
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c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Note that the region is the origin of the patients’ home resident region. Conditions marked ‘A’ overlap 
with other conditions and are thus not counted twice [1]. 
 
 
193 Emotionally unstable personality disorder 21,848 4.8 7,134 5.0 3,941 3.8 1,908 4.0 5,052 5.2 3,813 5.7 
194 Specific personality disorders 50,415 11.1 16,169 11.4 9,834 9.6 4,701 9.9 11,979 12.3 7,732 11.6 
195 Disorders of adult personality and behaviour 17,533 3.8 5,124 3.6 4,374 4.3 1,955 4.1 4,018 4.1 2,062 3.1 
196 Mental retardation 13,822 3.0 3,635 2.6 2,872 2.8 1,441 3.0 3,799 3.9 2,075 3.1 
197 Disorders of psychological development 9,911 2.2 2,681 1.9 2,896 2.8 1,128 2.4 1,790 1.8 1,416 2.1 
198 Hyperkinetic disorders (ADHD) c 42,908 9.4 11,440 8.1 13,401 13.1 4,548 9.6 6,843 7.0 6,676 10.0 
199 
Behavioural and emotional disorders with onset 
usually occurring in childhood and adolescence 
39,602 8.7 14,794 10.5 5,190 5.1 4,746 10.0 9,686 9.9 5,186 7.8 
 Having one or more chronic conditions  2,989,441 656.2 881,379 623.7 674,263 657.0 315,842 664.0 668,525 685.1 449,432 676.3 
              
 Depression medicine c    ** 529,918 116.3 141,371 100.0 129,338 126.0 54,988 115.6 126,599 129.7 77,622 116.8 
 Antipsychotic medicine c    ** 138,625 30.4 38,012 26.9 29,576 28.8 14,439 30.4 34,688 35.5 21,910 33.0 
 Indication prescribed anxiety medicine c    ** 102,568 22.5 28,692 20.3 24,733 24.1 11,011 23.2 22,108 22.7 16,024 24.1 
 Heart failure medication c    ** 7,468 1.6 2,404 1.7 1,838 1.8 693 1.5 1,265 1.3 1,268 1.9 
 Ischaemic heart medication c    ** 129,484 28.4 34,107 24.1 31,561 30.8 14,609 30.7 28,522 29.2 20,685 31.1 
 All of the five types of medicine  above 688,006 151.0 186,130 131.7 164,098 159.9 72,462 152.3 161,572 165.6 103,744 156.1 
              
 Others: arthrosis combined (M15-M19)  338,166 74.2 91,573 64.8 77,076 75.1 37,306 78.4 80,198 82.2 52,013 78.3 
 Others: overweight (E86) 220,928 48.5 56,808 40.2 46,843 45.6 23,295 49.0 53,541 54.9 40,441 60.9 
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Supplementary Material 6: Comments on Danish regional 
differences and overview regional differences by overall disease 
groups 
Overview of  regional differences 
Some national regional differences exists regarding mortality rates (see Figure 1), as 
well as education, age, fertility, ethnicity, local immigration and others [8,9]. For 
international comparision, national mortality rates are as follows: approximately 935 
deaths per 100.000 individuals alive in 2013; and for men, 938 deaths per 100.000 










Figure 1. Map of Denmark and full population age 16 years or above. Death per 
thousand is based on all ages (0+). Source: Statistics Denmark www.dst.dk. Figure 
adapted from Christensen et al., Figure 1 [10]. 
 
North Denmark Region 
Population: 475,637 (10%), 
hereof 50.1% men.  
Death per 100.000: 1,030, hereof 
1,046 per 100.000 men.   
 
Central Denmark Region 
Population: 1,026,349 (23%), 
hereof 49.9% men.  
Death per 100.000: 858, hereof 874 




Region of Southern Denmark  
Population: 975,809 (21%), 
hereof 49.5% men.  
Death per 100.000: 978, hereof 
985 per 100.000 men.  
 
 
Region Zealand  
Population: 664,573 (15%), 
hereof 49.2% men.  
Death per 100.000: 1,048, hereof 
1,066 per 100.000 men.  
 
 
Capital Region of Denmark  
Population: 1,413,071 (31%), 
hereof 48.4% men.  
Death per 100.000: 881, hereof 





































Men 2,242,422 49.2 684,398 48.4 509,611 49.7 238,114 50.1 483,450 49.5 326,849 49.2 
Women 2,313,017 50.8 728,673 51.6 516,738 50.4 237,523 49.9 492,359 50.5 337,724 50.8 
16–24 years 648,269 14.2 202,503 14.3 157,931 15.4 68,896 14.5 135,659 13.9 83,280 12.5 
25–34 years 650,285 14.3 248,639 17.6 147,460 14.4 61,819 13.0 122,329 12.5 70,038 10.5 
35–44 years 760,514 16.7 250,628 17.7 170,154 16.6 72,785 15.3 156,563 16.0 110,384 16.6 
45–54 years 801,708 17.6 239,637 17.0 177,291 17.3 83,943 17.7 175,777 18.0 125,060 18.8 
55–64 years 694,862 15.3 190,871 13.5 158,226 15.4 76,684 16.1 156,790 16.1 112,291 16.9 
65–74 years 594,029 13.0 166,541 11.8 127,600 12.4 64,949 13.7 133,759 13.7 101,180 15.2 
75 years or 
above 
405,772 8.9 114,252 8.1 87,687 8.5 46,561 9.8 94,932 9.7 62,340 9.4 
 
Method of defining ’differences‘  
Thus, prevalences are calculated from a specific point in time, using the five 
categories of chronicity and the corresponding inclusion times for each condition, as 
can be seen in the literature [1].   For national regional estimates, the respective 
population of each of the five regions was the denominator of the ratio.  
National regional differences were defined as ‘major’ if a difference of 50% or more 
between the highest and lowest prevalence across regions was found, and when the 
differences were also apparent after standardisation by age, gender and education.  
 
Results  
Some regional differences in prevalence exist, as can be seen in Supplementary 
material 4-5. In the following, conditions with ‘major’ regional variation, as defined in 
the Methods section, are commented upon.  
Overall, the Capital Region had the lowest prevalence of chronic conditions, with 
623.7 cases per thousand inhabitants, while the Region of Southern Denmark had the 
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highest overall prevalence, with 685.1 cases per thousand inhabitants (638.4 and 
677.1 standardised, respectively). 
However, in regards to, for example, HIV, the Capital Region had a higher prevalence 
than all other regions. The same pattern exists for skin cancer and melanoma. Within 
the ‘endocrine, nutritional and metabolic’ disease classification, it is mainly the rare 
condition cystic fibrosis that seems to vary across regions. Within ‘mental and 
behavioural disorders’, a few variations exist within ADHD, phobic disorders, other 
anxiety disorders and PTSD. Within ‘diseases of the circulatory system’, heart failure 
differs across regions, being about 50% as prevalent in the Capital Region as in the 
North Denmark Region, while angina is around 50% higher in the Central Region 
than in the Capital Region. With regard to ‘diseases of the musculoskeletal system 
and connective tissue’, some differences are seen for osteoporosis and some forms of 
osteoarthritis. Southern Denmark has around twice the number of osteoporosis 
patients as the region with the lowest (Zealand Region). Kyphosis/lordosis is almost 
twice as prevalent in the Capital Region as in the Southern and Zealand regions.  
 
Discussion 
Moreover, even within a homogeneous country such as Denmark, some ‘major’ 
regional differences are found for specific conditions, although other studies have 
found limited variation within regions [11]. Some differences are found within, for 
example, HIV, skin cancer and ADHD. In the case of HIV, the differences might be 
due to a higher concentration of homosexual environments in the Capital Region, 
while the higher prevalence of skin cancer in the Capital Region could be explained 
by the ‘metropolitan lifestyle’. However, in general, differences might also be 
explained by differences in ’practice style‘, as discussed in other studies [12,13]. For 
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example, the higher prevalence of ADHD in the Central Denmark Region could be 
explained by a stronger clinical environment and more specialists focusing on ADHD. 
Thus, differences in clinical environment, including the geographical concentration of 
specialised clinical centres, different reporting practices and incentives for economic 
settlement in reporting [1], cannot be ruled out in explaining other geographical 
differences found. However, with a few exceptions, only minor or no differences were 
found for most conditions.  
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Table 9. Regional overview by disease groups. N and prevalence of conditions and medicine for Denmark and the five regions – at 1 January 
2013 (Standardised rates or mean std dev. in brackets).  
c complex defined condition, see reference for further details [1]. ** 2-year prevalence. Note that the region is the origin of the patients’ home resident region. Conditions marked ‘A’ overlap 
Condition Denmark Capital Region of Denmark Central Denmark Region North Denmark Region 




 N Per thousand N Per thousand N Per thousand N Per thousand N Per thousand N Per thousand 
B –  Viral hepatitis and human immunodeficiency 
virus [HIV] disease 
8,813 1.9 (2.0) 4,044  2.9 (2,9) 1,862 1.8 (1,8) 485 1.0 (1,0) 1,465 1.5 (1,5) 957 1.4 (1,4) 
C – Malignant neoplasms 229,331 50.3 (50,4) 69,152 48.9 (52,5) 50,351 49.1 (50,5) 22,541 47.4 (45,5) 49,606 50.8 (48,6) 37,681 56.7 (52,0) 
D – In situ and benign neoplasms, and  neoplasms 
of uncertain or unknown behaviour and diseases of 
the blood and blood-forming organs etc. 
116,560 25.6 (25,7) 33,869 24.0 (25,4) 28,543 27.8 (28,3) 10,816 22.7 (22,1) 25,252 25.9 (25,0) 18,080 27.2 (26,0) 
E – Endocrine, nutritional and metabolic diseases  877,433 192.6 (192,7) 239,987 169.8 (184,6) 198,343 193.3 (197,8) 99,109 208.4 (198,4) 203,465 208.5 (198,9) 136,529 205.4 (188,7) 
G – Diseases of the nervous system 561,054 123.2 (123,5) 153,150 108.4 (113,3) 131,330 128.0 (130,1) 56,245 118.3 (116,3) 131,490 134.7 (131,9) 88,839 133.7 (128,0) 
H – Diseases of the eye and adnexa and diseases of 
the ear and mastoid process 
448,176 98.4 (98,6) 133,445 94.4 (101,4) 98,443 95.9 (98,5) 48,753 102.5 (97,7) 101,774 104.3 (99,3) 65,761 99.0 (92,2) 
I – Diseases of the circulatory system 1,254,427 275.4 (275,5) 344,337 243.7 (263,1) 276,838 269.7 (275,6) 141,084 296.6 (284,3) 292,077 299.3 (286,5) 200,091 301.1 (279,2) 
J – Diseases of the respiratory system 1,210,598 265.7 (266,3) 379,715 268.7 (273,4) 266,681 259.8 (261,8) 124,207 261.1 (259,8) 261,003 267.5 (265,6) 178,992 269.3 (264,1) 
K –  Diseases of the digestive system 329,337 72.3 (72,6) 95,452 67.5 (71,3) 71,490 69.7 (70,7) 34,486 72.5 (70,8) 74,822 76.7 (74,8) 53,087 79.9 (76,7) 
L – Diseases of the skin and subcutaneous tissue 65,469 14.4 (14,5) 22,064 15.6 (16,3) 14,781 14.4 (14,6) 6,049 12.7 (12,6) 13,003 13.3 (13,1) 9,572 14.4 (13,7) 
M – Diseases of the musculoskeletal system and 
connective tissue 
1,032,808 226.7 (227,1) 276,332 195.6 (205,2) 243,447 237.2 (241,1) 106,406 223.7 (218,8) 257,765 264.2 (257,5) 148,858 224.0 (213,0) 
N – Diseases of the genitourinary system 20,162 4.4 (4,5) 4,980 3.5 (3,9) 6,222 6.1 (6,2) 2,021 4.2 (4,0) 4,352 4.5 (4,2 ) 2,587 3.9 (3,6) 
Q – Congenital malformations, deformations and 
chromosomal abnormalities 
124,898 27.4 (27,5) 38,354 27.1 (26,5) 28,360 27.6 (27,6) 13,416 28.2 (28,9) 27,139 27.8 (28,3) 17,629 26.5 (27,6) 
F – Mental and behavioural disorders 683,194 150.0 (150,7) 197,626 139.9 (142,8) 155,979 152.0 (153,8) 67,510 141.9  (140,9) 161,658 165.7 (164,2) 100,421 151.1 (150,2) 
Having one or more chronic conditions  2,989,441 656.2 (657,2) 881,379 623.7 (638,4) 674,263 657.0 (663,1) 315,842 664.0 (657,3) 668,525 685.1 (677,1) 449,432 676.3 (658,6) 
Mean number of chronic conditions (std. dev) 2.2 (2,8) - 2.0 (2.7) - 2.2 (2.8) - 2.2 (2.7) - 2.4 (2.9) - 2.3 (2.8) - 
             
Depression medicine c    ** 529,918 116.3 (116,7) 141,371 100.0 (102,8) 129,338 126.0 (127,9) 54,988 115.6 (114,5) 126,599 129.7 (127,8) 77,622 116.8 (114,5) 
Antipsychotic medicine c    ** 138,625 30.4 (30,6) 38,012 26.9 (28,1) 29,576 28.8 (29,3) 14,439 30.4 (29,6) 34,688 35.5 (34,9) 21,910 33.0 (32,2) 
Indication prescribed anxiety medicine c    ** 102,568 22.5 (22,6) 28,692 20.3 (20,7) 24,733 24.1 (24,4) 11,011 23.2 (23,2) 22,108 22.7 (22,5) 16,024 24.1 (23,8) 
Heart failure medication c    ** 7,468 1.6 (1,7) 2,404 1.7 (1,9) 1,838 1.8 (1,8) 693 1.5 (1,3 ) 1,265 1.3 (1,2) 1,268 1.9 (1,7) 
Ischaemic heart medication c    ** 129,484 28.4 (28,5) 34,107 24.1 (27,2) 31,561 30.8 (31,5) 14,609 30.7 (28,3) 28,522 29.2 (27,2) 20,685 31.1 (28,4) 
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